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1 ABSTRACT 
 
Tuberculosis (TB) remains a global health emergency and one third of the global population 
harbour latent infection. A central tenet of TB pathology is that caseation of TB granuloma 
leads to matrix degradation and pulmonary cavitation, resulting in Mtb transmission and 
disease progression. However, lung destruction must involve activity of MMPs which are 
emerging as key proteases contributing to lung tissue pathology in TB. MMP-1 is the 
dominant collagenase in human pulmonary TB, but mice do not express an orthologue of 
human MMP-1 in the lung.  The precise relationship between the formation of caseous 
necrosis and lung matrix destruction has not been systematically examined, nor how the 
extracellular matrix (ECM) regulates the host-pathogen interaction. 
I investigated the effect of transgenic expression of human MMP-1 and -9 in the mouse on 
TB pathology and studied lung matrix integrity in human TB granulomas by ECM stains.  In 
cell culture systems, I developed a standard in vitro granuloma model and then progressed to 
3D and engineered models of TB granuloma and investigated the effect of modulating cell-
matrix interaction by introducing matrix components. 
In the mouse model, transgenic expression of human MMP-1 caused collagen destruction and 
caseous necrosis, suggesting that the initial event in caseation is collagen breakdown.  In 
human granulomas, ECM destruction and caseous necrosis co-localise, with loss of collagen 
fibres in areas of caseous necrosis.  Consistent with the hypothesis that matrix degradation is 
a key initial event in TB pathogenesis, I demonstrated that in cell culture models collagen 
improves survival of Mtb-infected cells. 
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I have re-considered the sequence of events underlying TB immunopathology and 
demonstrated that collagen destruction driven by MMP-1 is a critical initial event. This 
challenges current paradigms of disease pathology. These data demonstrate that the ECM 
regulates the host-pathogen interaction in TB. 
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5 INTRODUCTION 
 
5.1 The Tuberculosis epidemic 
 
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), has the highest mortality 
rate among the curable infectious diseases, killing almost 1.4 million people every year and 
infecting one third of world’s population (Dye and Williams, 2010). In 2012 it was expected 
that approximately 8.6 million of new cases of TB were diagnosed. Adding to this burden, the 
pathogen has developed resistance to first line drugs (Isoniazid and Rifampicin) (Gandhi et 
al.). These multi-drug resistant (MDR-TB), in addition to the evolving extensively drug 
resistant (XDR-TB) strains, are spreading widely to reach the incidence of more than 10% of 
the cases in some countries (Espinal et al., 2001). This may be due to limited access to health 
care centres, poor diagnostic laboratory resources and misuse of anti-tuberculous drugs. 
Furthermore, a limited number of totally drug resistant strains have recently emerged, 
suggesting that in some instances TB may revert to the pre-antibiotic era.   
Treating a patient with active TB with a fully sensitive organism requires daily administration 
of 4 drugs for two months, and then reduced to two drugs for another four months, or 3-times 
weekly treatment with directly observed therapy (DOTs). This six months course of treatment 
may lead to poor compliance and hence exacerbate the control programs by both failing to 
treat the patients and evolving of more resistant strains. The World Health Organization 
(WHO) has declared TB as global health emergency in 1993, however, there has been no 
significant improvement in the annual number of  TB cases and the standard antituberculous 
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treatment has remained unchanged for over 30 years, despite of investment in public health 
programs and extensive research (Raviglione and Smith, 2007).  
TB is the second cause of death from an infectious disease globally after AIDS. TB is also 
recognised as a disease of property, targeting young adults mostly. According to WHO 
reports, most of mortality cases by TB are reported in the developing world.  Largest 
numbers of cases are found in India and China, 26% and 12% of worldwide total, 
respectively. More than half of global TB cases were accounted in the South-East Asia and 
the Western Pacific Regions in 2012 (figure 1). 
 
 
 
Figure 1: Global TB Prevalence.    
Estimated number of new cases diagnosed with TB per 100,000 population worldwide. 
Global Tuberculosis Control, WHO, 2011. 
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Bacille Calmette-Guérin (BCG) vaccine was developed in Lille by Albert Calmette and 
Camille Guérin who performed serial culture of Mycobacterium bovis (M. bovis) until it 
became attenuated (Luca and Mihaescu, 2013). BCG vaccine has been administered to 4 
billion people worldwide over the last decades demonstrating its high safety and low cost 
(Gupta et al., 2007). However, the studies estimating the protection provided by BCG 
vaccination against adult pulmonary TB diverge from nil to 80% (Fine, 1995). BCG inter-
strain variation, genetic and environmental factors and exposure to environmental 
mycobacterial infection have been suggested to contribute to this wide inconsistency. 
Therefore, there is a need for more efficient and effective therapy to prevent spread of Mtb 
and treat people already exposed to the pathogen. To achieve this, it is essential to understand 
the molecular mechanisms of Mtb pathogenesis in order to develop better vaccine candidates 
and target-specific drugs for the treatment of TB.  This requires basic research into the TB 
pathology. 
 
5.2 Pathogenesis of M. tuberculosis infection 
5.2.1 Clinical features 
Mtb is the causative pathogen of the majority of TB cases and was first discovered in 1882 by 
Robert Koch. The microbe has a thick cell wall composed of primarily lipids such as mycolic 
acid. Therefore, it is neither classified as Gram positive nor Gram negative, and instead it is 
detected by Zeihl-Neelsen staining as acid fast bacilli due to the impervious feature of their 
lipid cell wall (Brennan, 2003). 
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TB primarily targets the lung but it may affect other parts of the body. The typical 
presentation of TB patients involves chronic cough, night sweats and loss of weight (Huebner 
and Castro, 1995). Extrapulmonary TB (miliary TB) is not common compared to pulmonary 
disease; however, the clinical course of the disease is usually associated with more serious 
outcome. Miliary TB usually occurs in very young infants or those immunocompromised 
though may occur in the face of an efficacious immune response, Mtb is transmitted from 
person to person through airborne droplets as the microbe can remain in the atmosphere for 
several hours. Inside the lung, the microbe is initially phagocytosed by alveolar macrophages 
that are thought to present Mtb antigens to CD4+ T cells and initiate a sequence of events 
directed to killing of the microbe (Dreher and Nicod, 2002). However, some bacilli survive 
despite the hostile environment inside the macrophages and are thought to replicate within 
unactivated macrophages (Dorhoi et al., 2011). 
 
5.2.2 Mtb in macrophages 
Phagosome–lysosome fusion is important in inhibiting the growth and killing of Mtb residing 
in macrophages (Meena and Rajni, 2010). Once the pathogen is phagocytosed, the tubercle 
bacilli are subjected to phagolysosomes’ killing mechanisms (McDonough et al., 1993). 
However, more recently it has been reported that some bacilli can exit the phagosome into 
vacuoles in the cytosol through studies of long term culture of Mtb within cells (van der Wel 
et al., 2007), although the importance of this mechanism remains controversial in the TB 
field. Moreover, Mtb can inhibit phagosomal maturation and acidification, other mechanisms 
employed by macrophages to destroy the microbe (Finlay and Falkow, 1997). Exclusion of 
the vesicular proton ATPase is suggested to contribute to the lack of acidification of 
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mycobacterium phagosomes (Sturgill-Koszycki et al., 1994). In addition, PE_PGRS proteins 
of Mtb have been suggested as a virulence factor (Iantomasi et al., 2012). Phagosome-
lysosome fusion was inhibited after inactivating PE_PGRS rendering human and murine 
macrophages attenuated.  
As the microbe persists in latent stage inside macrophages, it down regulates many genes that 
encode protein translation or metabolism and express others needed for stress responses 
(Muttucumaru et al., 2004). As part of the innate immune response, macrophages harbouring 
Mtb initiate a sequence of events, such as cytokine and chemokine secretion leading to a 
recruitment of more inflammatory cells. 
 
5.2.3 Cytokines in TB 
Cytokines play vital roles in the host immune response to Mtb and are important for host 
protection but also may cause tissue damage if secreted excessively (Casadevall and Pirofski, 
2003). IFN-γ, TNF-α, IL-12 and IL-1β are important cytokines involved in immune response 
to tubercle bacilli. A rare genetic defect in the IFN-γ receptor 1 gene was found associated 
with increased susceptibility to mycobacterial infection (Newport et al., 1996). Treatment of 
Rheumatoid Arthritis and Crohn's disease patients with anti-TNF medication increases their 
incidence of TB reactivation (Keane et al., 2001).  
In addition, IFN-γ and IL-2 concentrations in the lung were found elevated in patients with 
more severe pulmonary TB manifestations and decreased after anti-tuberculous treatment 
(Tsao et al., 2002). Flynn’s group demonstrated the protective role of TNF-α against TB 
infection in mice. They disrupted the TNF-α receptor gene and observed poor control of Mtb 
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which was associated with decreased production of Reactive Nitrogen by macrophages early 
during Mtb infection (Flynn et al., 1995).  
Chemokines are important in recruiting immune cells from blood to the site of infection. 
Upregulation of IL-8 gene expression and secretion was significantly increased in both 
bronchoalveolar lavage (BAL) and supernatants of macrophages of patients with pulmonary 
TB (Zhang et al., 1995). Increased concentrations of various chemokines such as MIP-1α and 
MCP-1 have been reported in BAL and serum of TB patients as well as human monocytes 
and macrophages after infection with Mtb (Saunders and Britton, 2007). 
Macrophages then track to draining lymph nodes in the mediastinum and results in antigen 
presentation (Cooper, 2009), developing potent cell mediated immunity (CMI). This CMI 
ultimately leads to the formation of a granuloma, the pathological hallmark of tuberculosis 
(Parks et al., 2004).  
 
5.2.4 Granuloma formation in TB 
Human TB granulomas consist of few tubercle bacilli surrounded by macrophages/monocytes 
and lymphocytes with a rim of fibroblasts formed around the granuloma to stabilise the 
structure. It has long been thought that the granuloma provides the body with protection by 
containing the pathogen and preventing its spread out of the lesion (Flynn and Chan, 2005, 
Ulrichs and Kaufmann, 2006). However, more recently a concept is emerging that the 
microbe expresses virulence factors that subvert immune responses and lead to the 
employment of host factors, such as TNF-α, for the granuloma formation and maturation 
(Kaplan et al., 2003). This suggests that Mtb benefits from granuloma in terms of 
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proliferation and dissemination, instead of merely remaining quiescent inside macrophages 
for decades by avoiding immune surveillance and macrophage killing mechanisms (Paige and 
Bishai, 2010).  
Ramakrishnan and her group have shown that granulomas assist mycobacterial growth, 
recruitment and infection of new macrophages in zebrafish infected with Mycobacterium 
marinum (Mm) (Davis and Ramakrishnan, 2009). The continuous cycle of death of infected 
macrophages and their phagocytosis by multiple newly recruited macrophages contribute to 
the expansion of early granulomas that subsequently disseminate by egress to form another 
granuloma at different site. They also suggest another mechanism of granuloma induction by 
M. marinum via RD1 virulence locus that encodes the ESAT-6 secretion system–1 (ESX-1) 
secretion system (Volkman et al., 2010). 
However, these studies are primarily based on the zebrafish embryo infection with M. 
marinum, which allows the dissection of macrophage migration due to the ability to visualise 
granuloma formation, but may have significant differences to M. tuberculosis infection of 
mammalian cells. 
 
5.2.5 Caseous necrosis and cavity formation in TB 
A pathological hallmark of human tuberculosis is the formation of caseous necrosis, which is 
the accumulation of necrotic material in the centre of a granuloma named for its amorphous, 
cheese-like material. Caseation of the granuloma and subsequent pulmonary cavitation are 
necessary for Mtb transmission and disease progression; however mechanisms leading to this 
lung tissue destruction pathology are poorly understood (Schluger, 2005).  
22 
 
Caseous necrosis is thought to result from Mtb-mediated macrophage cell death in the centre 
of the granuloma giving the tissue the pathognomic appearance (Cooper, 2009, Barry et al., 
2009, O'Garra et al., 2013) and excessive pro-inflammatory immune response may 
exacerbate tissue destruction (Cooper and Torrado, 2012). Under light microscopy, caseous 
necrosis appears as an amorphous pink matter that lacks intact cellular structure in 
Hematoxylin and eosin (H&E) stained sections. The caseous material in the granuloma was 
suggested to inhibit the growth of the Mtb because of the low pH, anoxia and abundant free 
fatty acids (Grange, 1998). 
The other hallmark in TB pathology is the formation of lung cavities. Pulmonary cavitation is 
recognised as a global health threat as patients with pulmonary cavitary lesions represent the 
major source of TB transmission (Nardell, 2000). This is partially because of the high 
mycobacterial burden around the walls of the cavities (Yoder et al., 2004). Pulmonary 
cavitation provides an environment that favours Mtb growth, with air rich in O2, CO2 and a 
neutral pH (Russell et al., 2010).  TB bacilli can then be transmitted to new host environment 
via aerosoliastion from the bronchial tree. 
The current model of TB pathogenesis suggests that caseous necrosis causes lung tissue 
degradation leading to the formation of pulmonary cavities (figure 2) (Russell et al., 2009, 
Russell et al., 2010). However, this paradigm does not explain the mechanism by which 
necrosis leads to cavity formation and overlooks the fact that Mtb must induce the breakdown 
of extracellular matrix (ECM), the principal support of the lung, to cause lung tissue 
destruction. The lung is highly resistant to matrix destruction and can withstand exogenous 
insults and therefore, Mtb must overcome this stable structure to transmit. 
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Figure 2: The current model of TB pathogenesis. 
Mtb is phagocytosed by alveolar macrophages followed by progressive recruitment of 
immune cells forming the granuloma. The structure is enforced by a rim of fibrous tissue and 
then the centre of the granuloma become necrotic because of cell death and form caseous 
necrosis that subsequently may then rupture into the airway and the cavity is formed. (Russell 
et al., 2010).  
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5.3 The extracellular matrix of the lung 
5.3.1 Lung extracellular matrix structure 
ECM in the lung is critical not only by providing a physical scaffold supportive structure but 
also by contributing to modulating cell behaviour (Streuli, 1999, Johnson et al., 2005). ECM 
in the lung is relatively stable even with prolonged exposure to cigarette smoke where most 
smokers found to have preserved lung function (Fletcher and Peto, 1977).  Rigidity and 
flexibility are essential features of ECM so that it can provide the tensile strength as well as 
accommodate the continuous fluctuations in alveolar volume during inspiration and 
expiration (Davidson, 1990). ECM components include collagen, elastin, fibronectin, 
Laminin and other proteins. The composition of the matrix varies from one site to another 
depending on the nature of that area and the function of matrix components involved. 
Collagen and elastin are key structural fibrils of the lung ECM. Type I collagen is the 
principal component of the  ECM in the lung that determines tensile strength (Montes, 1996), 
while elastin fibres are vital for alveolar wall elasticity (Rocco et al., 2001). Collagen type IV 
is a non-fibrillar type that is mainly found in the basement membrane of epithelia. 
Fibronectin is another component of the lung matrix, although some forms are soluble and 
found in the plasma. It contains binding sites that bind components of ECM like collagen and 
fibrin. Also, it play roles in cell adhesion, migration and morphology (Dunsmore and 
Rannels, 1996). Laminin and proteoglycan are other ECM components playing roles in 
variety of functions such as providing binding sites for receptors and promoting cell-matrix 
adhesion.  
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5.3.2 Cell-matrix interaction 
For long time, ECM was believed to be merely a ground substance that was functioning as a 
structural support for cells. However, more recently research has shown that in addition to 
forming a barrier isolating tissues from each other, ECM is important in cell migration, 
providing signals that modulate cell behaviour and acting as an environment sequestering 
biological compounds like growth factors (Cotran, 1999). Although matrix regulation of host 
immune response to TB has various implications, the role of ECM is not widely considered in 
the literature (Cooper, 2009, O'Garra et al., 2013, Ramakrishnan, 2012).  
Several essential processes in the immune response are influenced by cell-matrix interactions. 
For instance, monocytes derived macrophages (MDMs) adherent to type I collagen revealed 
significant antifungal activity by modulating phagolysosomal fusion capacity of Histoplasma 
capsdatum (Newman et al., 1997). Merline’s group demonstrated that matrix components 
played pro-inflammatory role of in sepsis and controlled tumour growth (Merline et al., 
2011). Furthermore, ECM modulates other immune responses like autophagy (Lock and 
Debnath, 2008) and immune cell activation (Sorokin, 2010). In addition, ECM acts like a 
pool to provide cytokines and other immunological mediators secreted by immune cells in 
areas of inflammatory reactions to modulate immune response.  
 
5.3.3 Extracellular matrix breakdown 
Although ECM is a well organised structure that undergoes continuous remodelling 
influenced by neighbouring cells, it is highly resistant to destruction. Matrix breakdown has 
been linked to various pathological conditions in the lung. Excessive degradation of 
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interstitial elastin leads to reduced lung compliance and affects the adequacy of ventilation of 
airspaces in patients with pulmonary emphysema (Davidson, 1990). Furthermore, the 
imbalance between collagen synthesis/degradation, where there is more collagen deposition 
has been reported in lungs of patients with idiopathic pulmonary fibrosis (Selman et al., 
1986). In TB pathology, the breakdown of lung ECM is an essential step in the granuloma 
leading to the formation of pulmonary cavities.  
The biochemistry of the lung matrix suggests that the matrix metalloproteinases (MMPs) may 
be contributing to lung destruction as they are the only proteinases able to cleave lung ECM 
at neutral pH (Brinckerhoff and Matrisian, 2002).  
 
5.4 Matrix metalloproteinases 
 
MMPs are known to play important roles in cell-cell and cell-ECM interactions (Vu and 
Werb, 2000). They are a family of 24 zinc dependant endopeptidases sharing a common 
catalytic domain structure but varying in cellular sources, regulation and substrate specificity 
(Gross and Lapiere, 1962). Typical MMP enzymes compose of a pro-peptide, a catalytic 
metalloproteinase domain, a linker peptide and a hemopexin domain (Overall, 2002). 
Collectively, MMPs are capable of degrading all fibrillar components of ECM at neutral pH 
(Gross and Lapiere, 1962). Based on their substrate specificity, they can be classified into 
collagenases, gelatinases, stromelysins, elastases and membrane type MMPs (Huxley-Jones 
et al., 2007) (figure 3). However, there is partial overlapping substrate specificity and some 
MMPs may act on different proteins (Parks and Shapiro, 2001). Although MMPs can cleave 
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multiple substrates in vitro, due to the promiscuous nature of proteolytic cleavage, it can be 
difficult to determine their true in vivo substrates, and conclusions drawn from purely in vitro 
experiments should be interpreted with caution (Parks et al., 2004). 
 
 
Figure 3: Categories of matrix metalloproteinases (MMPs). 
MMPs are zinc dependant endopeptidases that can be classified based on their substrate 
specificity to Collagenases, Gelatinases, Elastases, Stromelysins, Membrane-type and other 
MMPs (Vu and Werb, 2000). 
 
MMPs play key roles in physiological processes such as morphogenesis, wound healing, 
reproduction and tissue repair. Furthermore, MMPs play an important role as 
immunoregulators acting by proteolytic processing of cytokines and chemokines to modify 
their activity (Parks et al., 2004). For example, MMP-9 can cleave recombinant human IL-1β 
precursor into biologically active form while incubating MMP-3 with active IL-1β can 
degrade the active form of the mediator and inactivate it (Schonbeck et al., 1998). Therefore, 
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MMPs can both activate and inactive cytokines and chemokines. Excess MMP activity is 
linked to various disease pathologies characterised by abnormal matrix degradation such as 
chronic obstructive pulmonary disease (COPD), arthritis, tumour metastasis, atherosclerosis 
and tuberculosis (Segura-Valdez et al., 2000).  
MMPs are rarely stored but are tightly regulated at multiple levels including at the level of 
new gene transcription, secretion as pro-enzymes (Van Wart and Birkedal-Hansen, 1990), 
compartmentalisation and the secretion of inhibitors (Elkington and Friedland, 2006). In the 
pro-enzyme state, the N-terminal tail occupies the catalytic domain requiring cleavage for 
activation known as the (cysteine switch) (Van Wart and Birkedal-Hansen, 1990). Tissue 
inhibitors of metalloproteinases (TIMPs) are specific inhibitors that bind MMPs non-
covalently in a 1:1 manner to inactivate them (Brew et al., 2000).  
MMPs can be expressed and secreted by both inflammatory and stromal cells; however the 
profile is both cell and stimulus specific (Segura-Valdez et al., 2000). MMPs have been 
found to cleave other members of the MMP family in addition to their non-specific inhibitors 
such as α1-antiproteinase, suggesting a complex cascade determining turnover of the ECM 
(Desrochers et al., 1991). Consequently, investigating MMP activity in simple cell culture 
systems may well not reflect the much more complex balance between pro-enzymes, active 
proteases and their inhibitors that will take place in vivo at the site of inflammation. 
 
5.5 MMPs in TB 
The role of extracellular proteases in TB has not been a central focus for the field but there 
has been a recent increase in interest (Murphy and Nagase, 2008). In 1996, Chang et al. 
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provided the first evidence implicating MMPs in TB by demonstrating that Mtb and its major 
cell wall component, LAM, increased MMP-9 gene expression and secretion from infected 
THP-1 cells and increase in MMP-1 gene expression in both THP-1 cells and peripheral 
blood monocytes (Chang et al., 1996). Another study demonstrated increased MMP-9 
secretion from THP-1 cells and monocytes after infection with Mtb (Price et al., 2001).  In a 
gene expression approach, multiple MMP genes have been found upregulated in bone 
marrow-derived macrophages in response to Trehalose 6,6’-dimycolate (TDM), a 
mycobacterial cell wall glycolipid that is involved in virulence (Sakamoto et al., 2013).  
 
5.5.1 Source of MMPs 
The primary source of MMPs at site of infection is macrophages, which form the centre of 
the granuloma (North and Jung, 2004). Mtb infection of human macrophages has been shown 
to upregulate MMP-1 and -7 gene expression and secretion and to less extent MMP-3 and -10 
(Elkington et al., 2005b). However, pulmonary epithelial cells, compromising about 25% of 
total cell number in the lung, have been demonstrated as a potential key source of MMP-1 
and MMP-9 (Elkington et al., 2005a, Elkington et al., 2007) .
 
Direct infection of pulmonary 
epithelial cells with Mtb has shown no MMP-9 up-regulation, whereas conditioned media 
from Mtb infected monocytes (CoMtb) has driven MMP-9 gene expression and secretion by 
pulmonary epithelial cells, suggesting a synergy between factors derived from both host and 
pathogen (Elkington et al., 2007). Supporting this hypothesis, combined TNF-α and TB 
supernatant drives greater increase in MMP-9 up-regulation compared to either stimulus 
alone. Mtb infection of monocytes increases TNF-α secretion which then stimulates MMP-9 
secretion. Inhibiting TNF-α is associated with decrease in MMP-9 concentration. 
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5.5.2 MMPs in pulmonary TB 
MMP-1, -2, -3 and -8 concentrations increased in induced sputum of pulmonary TB patients 
compared to healthy people (Walker et al., 2012). However, MMPs were found less 
upregulated in patients with TB/HIV co-infection, where lung tissue destruction is less 
compared to TB only patients. The same study has shown the positive correlation between 
increased MMP-1 and -2 levels and the severity of TB disease in terms of presence of lung 
cavitary lesions and chest x ray severity. In a cell culture system, primary human 
macrophages up-regulate gene expression and secretion of MMP-1 and -7 progressively after 
infection with Mtb (Rand et al., 2009). Monocytes and macrophages have been shown to 
induce secretion of oncostatin M (OSM) that is involved driving MMP-1 and -3 up-regulation 
and TIMP down-regulation by human pulmonary fibroblasts (O'Kane et al., 2008).  
Recently, our group has shown that MMP-1 is increased in sputum and bronchalveolar lavage 
samples from TB patients (Elkington et al., 2011). Moreover, Mtb-infected primary human 
monocytes selectively up-regulate MMP-1 gene expression and secretion and MMP-1 
activity was suppressed by a specific MMP inhibitor. To prove a functional effect, transgenic 
mice expressing human MMP-1 were infected with Mtb and it was demonstrated there was 
increased pulmonary alveolar destruction in granulomas and collagen degradation in areas of 
macrophage infiltration (Elkington et al., 2011). Further, another study in Lima showed that 
MMP-1, -2, -3, -8 and -9 concentrations were elevated in induced sputum of TB patients with 
MMP-1 and -3 were correlated positively with severity of disease (Ugarte-Gil et al., 2013). 
While patients showing improvement during treatment, MMP-1, -3 and -8 levels dropped 
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significantly whereas TIMP-1 and -2 levels were increasing suggesting a state of opposing 
the matrix degrading phenomena during TB treatment.  
 
5.5.1 MMPs in Central Nervous System TB 
In CNS TB, it was shown that MMP-9 concentrations were higher in cerebrospinal fluid of 
patients with TB meningitis and correlated with disease outcome (Price et al., 2003). The 
increase in MMP-9 in TB meningitis was associated with tissue damage in the form of focal 
neurological deficits, confusion, unconsciousness and death. In TB lymph nodes, strong 
immunoreactivity throughout the TB granuloma for MMP-9 was demonstrated and this was 
not balanced by increase in TIMP (Price et al., 2001, Price et al., 2003). Furthermore, MMP-1 
and -3 gene expression and secretion from human microglial cells increased in response to 
TB infection (Green et al., 2010). These two MMPs were stained positive in the brain 
biopsies from patients with CNS TB and were suppressed when treated with Dexamethasone, 
which may explain partially the efficiency of steroids in treating CNS TB patient.  
 
 
5.6 Animal models of Tuberculosis 
 
Various animal models have been used in the TB research field for decades. Although animal 
models provided valuable understanding to TB, finding a proper model that represent human 
infection closely has been challenging. Our limited understanding of human TB pathology in 
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addition to the unrealistic expectations have contributed to the argument between critics and 
supporters of TB animal models (Young, 2009). It is not surprising that animal models do not 
fully reproduce TB infection in humans because of the heterogeneous nature of TB infection 
amongst people and even different lesions in the same patient. Therefore, a specific animal 
model should be considered by researchers when the question they are trying to find an 
answer to can be addressed best in that model. 
 
5.6.1 Non-human primate model 
TB infection of the non-human primates shares characteristics of human pulmonary TB more 
than any other animal model (Gupta and Katoch, 2005). However, the use of non-human 
primate model in TB field was hampered by the high cost and biosafety containment level III 
space requirements in addition to the need for expert staff and ethical concerns. Capuano et 
al. showed that cynomolgus macaques infected with Mtb had active, latent and resolving 
clinical disease outcome similar to what seen in human TB infection (Capuano et al., 2003). 
Microscopically, granuloma structure was found similar to that observed in human 
pulmonary TB; and in monkeys with active TB disease caseous necrosis lesions were evident 
in the infection area. It has been suggested that macaque model is very important in studying 
human latent TB when Walsh et al. demonstrated that macaques infected with low dose of 
Mtb developed chronic localised pulmonary TB but not active disease (Walsh et al., 1996).  
Several MMPs have been shown to be involved in host immune response to TB infection in 
non-human primate model. Transcriptomic profiling of lung granulomas of TB-infected 
rhesus macaques has revealed significant changes during the course of the infection (Mehra 
et al., 2010). Early granulomas exhibited a pro-inflammatory phenotype gene expression; 
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however, within weeks of infection it was observed that latent granulomas were 
reprogrammed to down regulate these genes. Many MMPs such as MMP-1 and -9 were 
highly expressed during the early stage of granuloma formation but as TB progress into 
latency MMPs appeared to be down regulated. This may explain the role of these MMPs in 
the development of pulmonary TB granulomas in terms of breaking down the lung matrix as 
well as recruiting and activating immune cells and mediators. Therefore, it is beneficial that 
more attention given to study non-human primate models and the role of MMPs in order to 
gain better vision into human TB and specially for vaccine development and drug testing 
(Langermans et al., 2005, Wolf et al., 1988).  
 
5.6.2 Rabbit model 
The use of rabbit model in TB research was also limited by the high cost of obtaining and 
maintaining the animals in the category 3 biosafety laboratories and by the lack of 
immunological reagents. The rabbit is an excellent model to study TB immunopathogenesis 
as it develops similar disease manifestations and lung pathology in terms of granuloma 
structure, caseous necrosis and cavity formation (Gupta and Katoch, 2005). It is the only 
available small animal model in which lung cavitary lesions can be investigated. The 
differences in response to TB aerosol infection between resistant and susceptible inbred 
rabbit strains have been demonstrated decades ago (Lurie et al., 1952). Unfortunately, these 
inbred rabbit lines were lost in a fire. Furthermore, the rabbits show different spectrum of 
disease after infection with different strains of Mtb (Manabe et al., 2003). After infection 
with a virulent strain of M. bovis, resistant rabbits have been shown to develop cavitary lung 
lesions similar to what seen in humans (Converse et al., 1996). On the other hand, susceptible 
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rabbits displayed a haematogenous spread of infection similar to immunocompromised 
humans. However, rabbits are difficult to be inbred and most of the rabbits available today in 
the market are resistant to TB (Flynn, 2006). 
MMPs have been studied in rabbit model of chronic TB infection and shown to be involved 
in host immune response, especially in early course of infection. Subbian et al. demonstrated 
the progressive up-regulation of MMP-1 from week 2 to week 8 post infection when the 
expression remained high throughout the course of the experiment (Subbian et al., 2011). 
This was associated with necrotic lung granulomas and cavitary lung lesions and high 
bacillary load. 
 
5.6.3 Guinea pig model 
TB infection of guinea pigs may be seen as an example of a failed immune response model as 
they are the most susceptible animal model to Mtb infection (Flynn, 2006). Very low dose of 
aerosolized Mtb causes a progressive disease and eventually all pigs die months to years later 
(McMurray, 2001). The granuloma structure formed in guinea pigs is well organised and 
become necrotic similar to human however cavities are rarely formed. Because of the early 
extrapulmonary dissemination of mycobacterial bacilli, it is a good model to study the 
primary and secondary lung pathology of TB (McMurray, 2001). BCG vaccination provides 
good protection to guinea pigs against Mtb infection and they show good response to anti-
tuberculous therapy making them good models to study the vaccine efficiency.  
Vaccinating guinea pigs with recombinant PknD sensor protein showed significant protection 
against dissemination to the brain after aerosol infection with Mtb (Skerry et al., 2013). In 
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addition, this model has been utilized to identify virulence factors by testing various mutants 
Mtb strains. For example, infecting guinea pigs with a streptomycin auxotrophic mutant Mtb 
strain 18b has led to human-like latent TB infection (Kashino et al., 2008). The advantages of 
this model include the smaller size of the animals making it easier to maintain in CL3 
laboratories, however, the immunological reagents are limited.  
 
5.6.4 Zebrafish model 
There has been an increase in interest in using zebrafish model in TB research. M. marinum 
(a natural host of zebrafish) and Mtb have been found genetically relative causing granuloma 
structure of TB-like disease (Talaat et al., 1998, Davis et al., 2002, Broussard and Ennis, 
2007). Investigators find this model very useful in examining mycobacterial pathogenesis for 
two main reasons. First, the embryos of the zebrafish lack the adaptive immune system 
allowing for studying the innate response in TB without the role of the adaptive system. 
Secondly, the transparency of the zebrafish embryos enables the researchers to monitor the 
early stages of M. marinum infection in terms of cellular recruitment to the developing 
aggregates (Stoop et al., 2011). However, the main drawback of this model is that zebrafish 
do not have lungs and that makes the correlation to the mammalian system unknown.  
Ramakrishnan’s group have been studying this zebrafish model to gain insight into TB 
pathogenesis. The TB granuloma progress and the spreading of mycobacterial bacilli into 
distal parts have been suggested to be through translocation of infected monocytes that have 
been recruited in the nascent granuloma. These recruited immune cells go through continuous 
cycle of infection/death and then seeds secondary granulomas in different locations (Davis 
and Ramakrishnan, 2009).  They also examined the molecular pathways showing that though 
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excess TNF is playing role in macrophage resistance to Mtb, it leads to macrophage lysis and 
extracellular growth of bacilli (Roca and Ramakrishnan, 2013). This was shown through 
mitochondrial reactive oxygen species (ROS) that drive TNF activation of programmed 
necrosis pathway.  
 
MMP-9, -13 and -14 have been shown to be up-regulated in zebrafish model when infected 
by virulent Mtb strain more than attenuated strains, though most of the other genes profiled 
showed no difference in expression  (van der Sar et al., 2009). An important study showing 
the immunomodulatory role of MMPs came from the zebrafish model of M. marinum 
infection. Granuloma formation and macrophage recruitment were deficient in MMP-9 
knockout zebrafish following infection with TB (Volkman et al., 2010). Moreover, it has 
been demonstrated that 6-kD early secreted antigenic target (ESAT-6), a mycobacterial 
secreted protein implicated in virulence since it is expressed in the RD1 (region of difference 
1), increases MMP-9 secretion from epithelial cells adjacent to infected macrophages, 
thereby recruiting more macrophages to the developing granuloma (Davis and Ramakrishnan, 
2009). However, the substrate for MMP-9 has not been identified in this model system and 
the relevance to mammalian systems is unknown. 
 
5.6.5 Mouse model of TB 
The mouse model is a very well recognised and economical experimental model to study TB. 
The availability of genetically modified mouse strains, relative low cost of purchasing and 
maintaining, inbred strains and the wide range of immunological reagents made the model 
preferable in TB research (Flynn, 2006). The different spectrum of TB disease research 
37 
 
included immune response, Mtb mutants, drug testing and vaccine development. However, 
the model is limited by the fact that the granuloma structure is not well organised making 
different microenvironment in the host which is affecting the interaction between immune 
cells and the pathogen. Furthermore, the mycobacterial burden in the mouse lung is high even 
though infection is controlled (Rhoades et al., 1997). Aerosol infection of mice with Mtb is 
relatively easy, requiring only low dose of microbes to establish an infection in the lung and 
subsequently spread to other parts of the body.  
There is a broad range of susceptibility/resistance of inbred mouse strains to TB infection 
depending on their genetic background (Medina and North, 1998). Mouse strains can be 
classified to susceptible or resistant by their median survival time after infection. Susceptible 
mice fail to control mycobacterial replication which leads to inflammatory reactions and 
fibrosis in the lung interfering with oxygen exchange and mice die early (less than 114 days). 
On the other hand, resistant strains shows better control to Mtb growth forming granuloma-
like structures that minimise lung injury allowing them to survive longer (more than 250 
days) (Chackerian and Behar, 2003). Susceptible mouse strains include CBA, DBA/2, C3H 
and 129/SvJ and researchers found them good candidates for vaccine development testing. 
Resistant strains include BALB/C and C57BL/6 (Medina and North, 1998) and preferred for 
studies of latent infection.  
The Cornell mouse model of latency (McCune and Tompsett, 1956, McCune et al., 1956) 
was developed in 1956 when mice were infected by high dose of Mtb and then received 
chemotherapy and showed that no bacilli were detected in lungs and spleen. After 3 months 
of terminating the antituberculous treatment, some of the mice developed a reactivation and 
when immunosuppressants were administered, reactivation occurred in almost all of them. 
Mycobacterial bacilli cultured from relapsed mice were sensitive to the antituberculous 
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agents, suggesting that tubercle bacilli were resistant to drugs during dormancy (Gupta and 
Katoch, 2005).  
Immunity to Mtb in mice is similar to that seen in humans in terms of the role of CD4+ve T 
cells, TNF-α and IFN-γ. Interference with IFN-γ has rendered mice more susceptible to Mtb 
infection and patients with mutations of the IFN-γ/IL-12 signalling pathway are 
hypersusceptible to mycobacterial infection (Flynn et al., 1993, Cooper et al., 1993). 
Similarly, the developing granuloma was shown to be TNF-α dependant as demonstrated by a 
delayed onset of granuloma formation in TNF-deficient mice (Algood et al., 2005, Saunders 
and Britton, 2007). Furthermore, poor granuloma formation and bacterial elimination has 
been shown in mice infected with BCG with prior administration of anti- TNF-α (Kindler et 
al., 1989). Consequently, similar cytokines are important in controlling TB in both human 
and murine models. 
The classical histological changes in the resistant mice chronically infected with TB involves 
the formation of granuloma-like aggregates that limit mycobacterial growth and reduce lung 
tissue injury, therefore, survive longer than susceptible strains (Chackerian and Behar, 2003). 
Mice normally exhibit fibrotic lung pathology but not caseation, multinucleate giant cell 
formation nor cavitation seen in humans infected with Mtb, even with high bacterial loads 
(Orme, 1998).  This tolerance suggests that mice are deficient in factors of innate immune 
responses driving immunopathology. It has been demonstrated by Kramnik’s group that Ipr1 
gene located in the sst1 locus is important in mediating mouse immune response to TB (Pan 
et al., 2005). They showed that congenic mouse strains developed histological changes in 
their lungs that share similarities to human TB infection by forming granulomas with necrotic 
centre. However, the mouse model they have used is not fully immunocompetent and the 
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infectious dose was high, with very high mycobacterial loads within granulomas, which does 
not reflect human disease where bacilli are relatively scanty.   
MMPs have been implicated in the spread of TB in infected mice as infection of MMP-9 
deficient mice was associated with decreased dissemination of the bacilli (Taylor et al., 
2006). Mtb infected mice treated with broad spectrum MMP inhibitor, BB-94, had shown 
limited immune cells recruitment, less bacterial dissemination and smaller granulomas (Izzo 
et al., 2004), but a comprehensive analysis of the role of MMPs in TB has not been 
performed. 
 
5.7 Cell culture models of TB 
 
The majority of cell culture research in TB centres on either primary cells or cell lines grown 
in standard culture systems.  The cellular source may either be mouse or human, and human 
cells are either peripheral blood mononucleated cells (PBMCs) or in vitro differentiated 
macrophages or dendritic cells.  While a significant amount of information about TB can be 
gathered from these systems, they are clearly only an approximation to events in vivo.  
Various models have been developed to try to represent the more complex interplay that takes 
place between cells and mycobacteria in human infection. 
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5.7.1 Standard cell culture modelling 
There are some attempts to develop cellular models of human TB granulomas to examine 
different aspects of the model. Frederic Altare’s group in France has established an in vitro 
granuloma model using both mycobacterial antigens and live mycobacteria incubated with 
PBMCs from healthy donors with monitoring for up to 21 days (Puissegur et al., 2004, 
Puissegur et al., 2007, Russell et al., 2009, Lay et al., 2007). The model showed the typical 
progressive recruitment of macrophages surrounding the microbe or its antigen and the 
development into epithelioid cells and multinucleated giant cells (MGCs), mimicking the 
naturally occurring granuloma. Furthermore, they have demonstrated that MGC induction by 
mycobacterial cell wall antigen lipids is mediated by Toll-Like Receptor 2 (TLR2). In 
addition, Mtb induced MGCs were demonstrated to be unable to mediate bacterial 
phagocytosis even though the ability to present the antigen was conserved.  Therefore, this 
model has allowed the detection of mycobacterial determinants of granuloma formation in 
vitro but the role of extracellular proteases in this system has not been investigated. 
Some other researchers also developed an in vitro model of human TB where granulomas 
progress into latent state and then they can be reactivated again by immunosuppressant 
(Kapoor et al., 2013). Changes that demonstrate latency in these granulomas include loss of 
acid fastness of mycobacterial bacilli, deposition of lipid bodies, Rifampicin resistance and 
upregulation of relevant dormancy-related genes. The addition of Anti-TNF-α antibodies to 
the dormant granulomas caused reactivation where Mtb showed more acid fast staining, 
Rifampicin tolerance and upregulation of genes involved in active infection. They also 
demonstrated that interfering with triacylglycerides (TG) synthesis by triacylglycerol 
synthase1 deletion rendered these granulomas unable to progress into latent stage. Likely, 
dormant granulomas failed to reactivate after TNF-α neutralisation when lipY gene that 
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mobilise stored TG was deleted. This model may be useful in examining the functional 
characteristics of dormant and resuscitated TB granulomas. 
Birkness et al. have also developed an in vitro model of human granuloma where PBMCs and 
autologous macrophages were infected with Mtb and monitored for 9 days (Birkness et al., 
2007). Granuloma-like aggregates started to form early after infection and increased in size 
during the time course of the experiment. These aggregates composed of epithelioid 
macrophages and T-cells in addition to MGCs as well as Mtb bacilli which may be within or 
between the cells. They have also examined the cytokine and chemokine secretion patterns in 
the supernatant of these granulomas. IL-2, IL-4, IL-10 and IL-12 were either undetected or 
very low in concentrations, whereas TNF-α, IFN-γ, IL-8 and IL-6 were upregulated in Tb 
infection in three different donors. TNF-α peaked at day 2 followed by a decrease in 
concentration and IFN-γ level was low in the first two days then peaked at day 5 after 
infection. The authors have also demonstrated that supernatant from Mtb-infected 
macrophages attracted more cells than supernatant from uninfected macrophages. However, 
this model did not assess cell viability in their model. 
In addition, Makino’s group in Japan have developed an in vitro granuloma model similar to 
the previous model but using Mycobacterium leprae (M. leprae) instead of Mtb (Wang et al., 
2013). Human macrophages infected with M. leprae and co-cultured with autologous PBMCs 
for 9 days and showed the progressive recruitment of immune cells to the granuloma-like 
structure. Cytokines were screened in this model and showed upregulation of IFN-γ, TNF-α, 
IL-1β, Il-2, Il-4, IL-12p40 and IL-13. In a different approach, others have utilised an 
experimental human lung tissue model using human lung derived cell lines and primary 
macrophages from peripheral blood (Parasa et al., 2014). Mtb-infected macrophages formed 
cellular aggregates at site of infection but not the RD1 deficient Mtb strain.  
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5.7.2 3-Dimensional cell culture modelling 
Most cell culture models in cell biology are carried out by growing cells in a monolayer 
technique on rigid plastic or glass substances. Though this approach is widely accepted in 
medical research and proven to provide essential insights in many fields, a 3 dimensional 
(3D) cell culture systems would minimise the gap difference between cell culture and the 
normal physiological conditions of the tissue (Pampaloni et al., 2007). Cells grown in the 
relevant 3D structure would provide information about cell behaviour more closely than the 
standard cell culture system where the cells lack the interaction with their specific 
environment. Specific cell-cell and cell-ECM interactions in normal and malignant mammary 
glands can be modelled using 3D cell culture technique to identify the relationship between 
cell functions and tissue architecture to generate insight into mechanisms of breast cancer 
progression (Bissell et al., 2002).  
Primary human mononuclear cells were used to develop a multicellular heterospheroids that 
have similar phenotype to human granulomas (Seitzer and Gerdes, 2003). In this model, 
authors have shown the aggregations of monocytes, B-cells and T-cells and also 
demonstrated the differentiation of monocytes to macrophages after 4 days of culture. Cell 
viability was monitored for 7 days and showed that spheroids consisted mostly of live cells. 
However, spheroids could not be developed when infection cells with high mycobacterial 
load but instead only very small aggregates formed of dead cells were observed. 
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Cell encapsulation is another method to generate 3D environment where cells can be mixed 
with different matrices to develop specific cell-matrix interaction changing cell behaviour 
and yielding results that mimic in vivo studies (Wang et al., 2001, Purcell et al., 2009). A bio-
electrospraying system has been shown recently that it can generate microspheres by 
injecting the polymer of choice through a nozzle so that droplets fall into a crosslinking bath 
where spheroids formed (Workman et al., 2014). Electric current can be applied around the 
nozzle to assist in microspheres generation and the voltage used was shown that it has no 
detrimental effect on cell viability.  
Microspheres generated can vary in their size based on different parameters that can be 
modified such as the flow rate of the polymer of choice, the diameter of the nozzle and the 
voltage. The microspheres can be generated to encapsulate different environments like 
PBMCs whether Mtb-infected or not, and also whether incorporated with ECM component or 
not. These modifications can allow researchers to study the consequences of immune cells 
interacted with different matrices when infected with Mtb. 
Taking the diverse evidence that cell-matrix interaction is significant contributor to lung 
pathology and that MMPs are critical players as well, I postulate that MMP-1 is causing lung 
alveolar destruction by direct collagen breakdown which eventually interfere with cell-matrix 
interaction. This project will aim to extend our understanding of the roles of MMPs in TB.  
  
44 
 
5.8 Hypothesis and experimental aims 
 
My hypothesis is that MMPs are critical regulators of mammalian TB granuloma formation 
and that ECM breakdown modifies the host immune response to TB. The specific aims of my 
project are to: 
 
I- Investigate the effect of expression of human MMP-1 and MMP-9 in transgenic 
mice infected with a virulent clinical Mtb strain 
II- Define the mechanisms of divergent pathology in MMP-1 and MMP-9 transgenic 
mice 
III- Develop an in vitro granuloma model of TB and define MMP expression in this 
model 
IV- Investigate the functional effect of MMP activity and matrix breakdown in the cell 
culture model 
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6 METHODS 
 
6.1 Mice colony Breeding and Genotyping 
C57BL/6 mice expressing either human MMP-1 or -9 were generated by Dr Jeanine 
D’Armiento, Columbia University, New York, and were provided as part of an ongoing 
collaboration between our groups.  Mice are bred in the animal facility in CBS at South 
Kensington. Mice were genotyped by extracting genomic DNA with Qiagen DNeasy Blood 
& Tissue kit from ear clipped tissue. Briefly, mouse tissue (ear or tail) was incubated at 56º C 
with 20 µl proteinase K and 180 µl Buffer ATL for 4 hours (or overnight) with occasional 
shaking to disturb the sample. Then, 200 µl Buffer AL was added and mixed thoroughly and 
another 200 µl ethanol was also added to the sample and vortexed.  
The mixture was then pipetted into the DNeasy Mini spin column placed in a 2 ml collection 
tube and centrifuged at 6000g for 1 minute. The mini spin column was placed a in new 
collection tube and 500 µl Buffer AW1 was added and centrifuged at 6000g for 1 minute 
followed by adding 500 µl Buffer AW2 and centrifugation at 20,000g for 3 minutes to dry the 
DNeasy membrane. The spin column was then placed in an autoclaved 1.5 ml tube and 100 
µl nuclease free water was added directly onto the DNeasy membrane and incubated for 1 
minute at room temperature and then centrifuged for 1 minute at 6000g to elute the DNA. 
After mixing with master mix, DNA was run in the PCR machine and the PCR product was 
loaded in 2% agarose gel and run for 1 hour at 100V. PCR resulted in 200bp and 800bp 
fragment products for MMP-9 and -1, respectively.  
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6.2  Mouse Infection, Dissection and sample processing  
 
The mouse experiments were approved by Home Office and performed in accordance with 
the appropriate project licence in the CL3 animal facility at South Kensington. C57BL/6 mice 
expressing either human MMP-1 or -9 were genotyped and sorted into cages. MMP-1 and -9 
are expressed under control of the scavenger receptor A promoter/enhancer. MMP-1 and -9 
and their wild-type littermates were infected intranasally with 5200 colony forming units 
(CFUs) Mtb 232 Indo-Oceanic strain passage 3 (minimum 5 mice per group) after being 
anesthetised with intraperitoneal xylene/ketamine. Mice were checked regularly for signs of 
distress and weighed fortnightly to determine if 20% weight loss occurred, which would 
necessitate sacrifice of the mice under Home Office licence. 
Experimental mice were sacrificed by terminal overdose of anaesthetic (Pentobarbitone) at 22 
weeks after infection and then dissected according to the lung protocol approved for use in 
the mouse containment room. Briefly, the dead mouse is placed on ethanol soaked tissue and 
immobilised using 5 pins. The skin was dissected off and the thoracic cavity was exposed. 
Then an intravenous cannula was inserted into the trachea and sutured into place, and a BAL 
fluid was performed with 1ml sterile Phosphate buffered saline (PBS). The left lung was 
clamped off and divided in two parts. Half was placed in RNAlater (Qiagen) for mRNA 
analysis, and half was placed in PBS for protein analysis and colony counting. The right lung 
was then inflated with formalin (Sigma) for 5 minutes under 20cm pressure using an 
intravenous giving set attached to a 50ml syringe. The lung was then immersed in formalin 
for 24 hours before change to 50/50 ethanol/PBS to prevent over-fixation.  Then the lung was 
embedded in paraffin and serial 3µm sections were then taken of the whole lung. H&E, 
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Masson’s Trichrome and Sirius red stains were performed and then digital images of the 
slides were acquired (Hamamatsu nanozoomer). 
For mRNA analysis, the lung was placed in 1ml Tri-Reagent (Sigma) with minimal handling 
to avoid contamination and dissociated by a sterile rotating blade homogenizer (Omni 
International) for 30 seconds inside the class I hood in the CL3 lab using secondary 
containment. Total mRNA was extracted and MMP-1 and -9 genes expression were analysed 
by PCR as above.  
 
6.3 Colony counting 
 
For protein analysis and colony counting, the mouse lung was placed in 1ml sterile PBS and 
disrupted by a sterile homogenizer for 30 seconds as above. 70µl was taken for colony count 
by plating serial 1:10 dilutions on 7H11 agar (BD Biosciences), and colonies were counted 
after 3 weeks of incubation at 37°C. Lung homogenate and BALF were first cleared by 
centrifugation at 13,000rpm, then sterile filtered through a 0.2µm filter (Millipore) and then 
transferred outside CL3 lab for further analysis. 
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6.4 Staining of lung sections 
6.4.1 Human lung sections 
The project was approved by the Hammersmith and Queen Charlotte's & Chelsea Research 
Ethics Committee (ref 07/H0707/120).  Lung biopsies from patients under investigation for 
probable lung cancer who had a final diagnosis of pulmonary TB were studied. 
Immunohistochemistry was performed on paraffin embedded lung biopsies from 6 patients 
with culture-proven Mtb infection and 6 non-infected controls. Lung sections’ staining was 
performed by the histology service at Imperial College London, South Kensington Campus. 
 
6.4.2 Mouse lung sections 
After dissection, the mouse lung was fixed in formalin for 24 hours then changed to 50/50 
PBS/Ethanol to avoid over fixation. The lung was then embedded in paraffin and multiples 
sections were taken from different parts of the lung. First, three sections (in one slide) for 
H&E staining were taken from the top of the lung followed by 12 blank sections (3 in a slide) 
for further immunohistochemistry. Then, another 3 sections for H&E followed by another 12 
blank sections were taken ending to the total of 12 H&E and 48 blank sections. 
 
6.4.1 H&E staining 
Mouse lung sections were dewaxed, rinsed in alcohol and then rinsed in water. Slides were 
then stained with Hematoxylin solution for 8 minutes at room temperature followed by a 5 
minutes wash in running water and then differentiated in 1% acid alcohol for 30 seconds. 
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Followed by a washing step in running tap water for 5 minutes, and then Bluing in 0.2% 
ammonia water or saturated lithium carbonate solution for 30 seconds to 1 minute. Slides 
were then washed in water and rinsed in 95% alcohol followed by counterstain in Eosin-
phloxine solution for 30-60 seconds then dehydrated, cleared in xylene and mounted. 
 
6.4.2 Masson’s Trichrome staining 
Mouse lung sections were dewaxed, rinsed in alcohol and then rinsed in water. Post fix 
sections in Bouins fixative at room temperature overnight then washed in running water until 
water runs clear. Celestin Blue/Harris Haematoxylin sequence was performed to stain nuclei 
(Celestin Blue 5 minutes wash then immerse in Harris Haematoxylin 5 Minutes. Differentiate 
and blue). Sections were then stained in Biebrich Scarlet-Acid Fuchsin solution for 15 
minutes then differentiate in 1% Phosphomolybdic Acid until collagen is almost completely 
decolourised. Collagen was counterstained with 0.2% Light Green in 2% Acetic Acid for 2 
minutes then rinsed in water. Slides were then dehydrated, cleared and mounted.  
 
6.4.3 Picosirius red staining 
Nuclei were stained with Celestin Blue/Harris Haematoxylin and slides were then stained in 
Picosirius Red (0.1% direct red 80 plus 0.1% fast green FCF dissolved in saturated 1.2% 
aqueous picric acid). Slides were then washed in acetic acid and water. Slides were 
dehydrated by rinsing in 70, 90, 100% IMS followed by a 3 changes of Histoclear before 
applying coverslip with DPX mountant (VWR). 
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6.4.4 Ziehl–Neelsen staining of Mtb 
Carbol-Fuchsin solution was prepared by mixing 2.5g Basic fuchsin, 250ml distilled water, 
25ml 100% alcohol and 12.5 melted phenol crystals and then sterile filtered. Carbol-Fuchsin 
solution was microwaved for 45 seconds and slides were allowed to stand in the hot Carbol-
Fuchsin solution for 5 minutes then washed in running water. Slides were then stained with 
1% Acid Alcohol (10ml hydrochloric acid and 990ml 70% Alcohol) until light pink and then 
washed with running tap water for 5 minutes before rinsed in distilled water. Slides were then 
stained with methylene blue for 30 seconds and then rinsed with distilled water before 
dehydrated, cleared and apply cover slip.  
 
6.4.5 Elastin van Gieson (EVG) staining 
Slides where stained with Verhoeff's hematoxylin (Alcoholic hematoxylin 20.0 ml, 10% 
ferric chloride 8.0 ml and Lugol's iodine 8.0 ml), washed and then differentiated in 2% ferric 
chloride solution. After checking microscopically for black fibres on a grey background, 
sections were rinsed and treated with 5% sodium thiosulfate to remove iodine. 
Counterstaining was performed with Van Gieson's stain (1ml of 1% Acid fuchsin and 45ml 
of saturated Picric acid) for 5 minutes then slides were dehydrated, cleared in xylene and 
mounted. 
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6.5 Mtb culture 
 
Mtb H37Rv (a kind gift of Prof R. Wilkinson, Imperial College London) and a clinical Mtb 
isolate, Indo-oceanic 232 (a kind gift from Dr Guy Thwaites, Imperial College London) were 
cultured in Middlebrook 7H9 medium supplemented with 10% ADC enrichment medium, 
0.2% glycerol and 0.02% Tween 80 with agitation at 100rpm at 37
o
C.  Culture growth was 
monitored with a Biowave cell density meter (WPA, Cambridge) and the Mtb was sub-
cultured when the optical density reached 1.00.  For infection experiments, culture at mid log 
growth at an optical density of 0.60 was used, which corresponded to 1 x 10
8
 – 2 x 108 CFUs 
per ml.  Optical density was correlated with CFUs by performing colony counts in triplicate 
on Middlebrook 7H11 agar supplemented with OADC enrichment medium and 0.5% 
glycerol. 
 
6.6 PBMCs isolation and infection 
 
PBMCs were isolated from either single donor buffy coats from the National Blood 
Transfusion Service, Colindale or fresh blood from healthy volunteers. The leukocytes were 
mixed 50:50 with Hanks’ Balanced Salt Solution (HBSS), layered onto Ficoll Paque 
(Amersham Biosciences, Little Chalfont, UK) and centrifuged at 480 rcf for 30 minutes. The 
mononuclear cell layer was removed and then washed a total of four times in HBSS, spinning 
down the cell pellet at 308 rcf after each wash.  Total PBMCs were calculated by counting 
the number of cells in a Neubauer counting chamber after incubation for 5 minutes at 37
o
C. 
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PBMCs were plated in 24 well plate at 1x10
6
 cells/well diluted in 1 ml of 10% AB serum in 
RPMI supplemented with 2mM glutamine and 10μg/ml ampicillin. PBMCs were then 
infected with Mtb at OD of 0.60 to result in a multiplicity of infection (MOI) at 0.001. This 
was optimised after performing initial experiments with various MOIs. 
 
6.7 Sterilisation of cell culture supernatants 
 
Following experiments involving infecting cells with Mtb, samples required removal of Mtb 
by filtration before analysis outside the CL3 laboratory. Samples were centrifuged at 
13000rpm for 5 minutes inside class I hood and then sterile filtered through 0.2μm PVDF 
Durapore filters (Millipore). 
 
6.8 Killing of Mtb by Ultraviolet (UV) irradiation 
 
In order to use whole live bacilli with intact extracellular proteins for experiments outside the 
CL3 suite, Mtb was exposed to high intensity UV light for 90 minutes. To perform this, 1ml 
Mtb at an optical density of 0.60 was pipetted into a 60mm sterile petri dish and sealed 
carefully around the edge with parafilm, ensuring that the parafilm did not obscure the base 
of the petri dish. A 100µl aliquot of Mtb was kept as a positive control for culture 
confirmation of killing. The petri dishes were then slid into a ziplock bag and exposed to UV 
radiation for 90 minutes with occasional gentle shaking to ensure a thorough exposure. UV 
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exposed Mtb were pooled in a 15ml falcon and then 100µl was plated onto three 7H11 agars 
plates and spread with sterile loops. A 100µl control untreated TB was plated onto a fourth 
7H11 agar plate. Plates showed no growth after six weeks of incubation at 37
o
C while the 
positive control showed excellent growth, confirming efficacy of sterilization.  At this point, 
it was safe to remove the UV killed Mtb from the CL3 suite. 
 
6.9 Staining Cells for Confocal Microscopy 
 
Confocal Microscope acquires images by scanning a fluorescently stained specimen with a 
focused beam of light from a laser and collecting the emitted fluorescence signals by a photo 
detector via a pinhole aperture which blocks background signals which are out-of-focus. 
Cell Tracker
®
 was used to stain PBMCs while DRAQ5
®
 was used to stain Mtb. Cell Tracker 
reagents are fluorescent chloromethyl derivatives that freely diffuse through the membranes 
of live cells. Once inside the cell, these mildly thiol-reactive probes react with intracellular 
components to produce cells that are both fluorescent and viable for at least 24 hours after 
loading. Cell Tracker Green has a relatively low pKa, which ensures that it will exhibit 
bright, green fluorescence in the cytoplasm at all physiological pH levels. DRAQ5 is a novel 
far-red fluorescent DNA dye that can be used in live cells in combination with other common 
fluorophores, especially GFP fusions & FITC-tags.  
Cell Tracker™ Green CMFDA (Invitrogen) was used to stain PBMC according to 
manufacturer’s instructions. Briefly, 9x105 PBMCs were re-suspended in 2ml RPMI then 1µl 
(10mM) Cell Tracker stain was added then incubated at 37°C for 30 minutes. Cells were then 
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centrifuged at 1000rpm for 5 minutes and the pellet was re-suspended in 6.25ml 10% AB 
serum in RPMI and 400µl was added to each well of a 4-well chamber slide. To stain Mtb, 
0.25µl (10µM) DRAQ5™ was added to 100µl Mtb at 103 CFU/µl and incubated at 37°C for 
5 minutes then centrifuged at 13000rpm for another 5 minutes to pellet mycobacterial bacilli. 
The pellet was re-suspended with 100µl sterile PBS. 10µl of stained Mtb was added to 
infection wells then the slide was incubated at 37°C. Slides were examined under Confocal 
Microscope (Leica) and images were acquired. 
 
6.10 Developing 3 Dimensional (3D) collagen Matrix Gel 
 
Developing a 3D collagen gel will allow the study of the degradation of the matrix in more 
similar environment to TB lung pathology compared to infecting cells in plastic tissue culture 
plates. Stained PBMCs infected with stained Mtb can be cultured in the matrix gel and 
visualised under confocal microscopy where Z-stack images can be acquired to follow 
granuloma development over time. Initially, PBMCs are isolated as above then a volume 
containing 1x10
6
 cells is pipetted into a 15 ml falcon and spun at 1000 rpm for 5 minutes. 
The pellet was then resuspended in 2 ml RPMI and 10mM Cell Tracker stain was added and 
the cells were incubated at 37º C for 30 minutes. While incubating the PBMCs, Mtb was 
stained as above and cell suspension mix was made.  
Cell suspension mix contained 2 ml of collagen solution (Advanced Biomatrix), sterile 0.25 
ml 10x RPMI, 0.25 ml NaOH in HEPES and 0.25 ml AB serum. The volume of the gel added 
to each well of a chamber slide was 400µl as this forms approximately 3µm gel thickness, 
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which is the maximum focal range of confocal microscopy. The PBMCs were then 
centrifuged at 1000 rpm for 5 minutes and the pellet was resuspended in 2 ml of collagen 
suspension mix solution and 400µl was plated in each well of the four well chamber slides. 
Then 10 µl of stained Mtb was added to the infection wells and the medium was pipetted up 
and down 10 times to ensure thorough mixing. The chamber slide was then incubated at 37º 
C for one hour to allow gelation and then observed under light microscopy for any clumps of 
cells. 200 µl of 10% AB serum RPMI was placed on top of the collagen gel and changed 
three times per week. The chamber slide was observed under confocal microscopy and the 
granulomas were monitored at different time points. 
 
6.11 Collagen/agar 3D In Vitro Granuloma 
 
I have adapted a 3D in vitro Granuloma (3D IVG) model where collagen is replaced by agar 
to assess cell survival in without collagen but with agar that form a 3D environment for the 
cells. Therefore, the same protocol used above to prepare a 3D IVG was followed except that 
the collagen mix was made of agar mixture instead of collagen one. 1.5% Cell culture grade 
agar (Sigma) was prepared by soaking 2.25g of agar in the tissue culture hood with 1M 
NaOH for 3 hours to remove endotoxins. The reagent bottle was then washed with endotoxin 
free minimum culture medium and 150ml ddH2O added and then autoclaved. 
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6.12 Cell Encapsulation using Electrostatic Bead Generator 
 
Freshly isolated PBMCs were embedded into alginate microspheres using an electrostatic 
bead generator (Nisco, Zurich, Switzerland). PBMCs were mixed with sterile alginate mix 
(1.5%, Sigma, UK) in HBSS without Ca/Mg, 1M HEPES and 7.5% NaHCO3 to a final 
concentration of 5x10
6
 cells/ml. Purified human collagen solution (VitroCol, Advanced 
BioMatrix) was added at 1mg/ml for alginate-collagen microspheres. UV killed Mtb H37Rv 
at multiplicity of infection (MOI) 0.1 was added to Mtb-stimulated spheres.  
Each cell suspension was injected into the bead generator at 10ml/hr under sterile conditions, 
with a 0.7mm external diameter bioelectrospray needle. Microspheres were formed by 
ionotropic gelling in 100mM calcium chloride solution (figure 4). Microspheres were washed 
twice with HBSS and then placed in complete RPMI supplemented with 10% AB serum at 
37
o
C in humidified 5% CO2.  Supernatant surrounding the microspheres was harvested at 
defined time points. 
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Figure 4: Bioelectrospray technology to generate 3D microspheres. 
Schematic diagram to illustrate the process of cell encapsulation in the engineered in vitro 
granuloma (EVG) model.  PBMCs were mixed with alginate, +/- collagen and +/- Mtb and 
then injected through a syringe into the bead generator at 10ml/hr under sterile conditions. 
Microspheres were formed by ionotropic gelling in 100 mM calcium chloride solution and 
then washed with HBSS before medium was added to the spheres and incubated at 37
o
C.  
 
6.13 Gelatin zymography 
 
Gelatin zymography was used to show the enzymatic activity of MMPs. This was 
demonstrated by separating proteins on a gelatin-embedded gel under non-reducing 
conditions, allowing re-construction of the tertiary structure of the enzyme during the 
washing steps. Incubation at 37
o
C was followed to facilitate enzymatic degradation of the 
58 
 
substrate.  Breakdown products diffuse out of the gel and areas devoid of protein were 
revealed as a light band on a dark background after staining with Coomassie blue.  Both pro-
enzymes and active forms are demonstrated as the pro-enzymes become activated during the 
process of electrophoresis. 
Cell culture supernatants with 5x loading buffer (0.25M Tris pH 6.8, 50% glycerol, 5% SDS, 
bromophenol blue) were run on an 11% acrylamide gel impregnated with 0.1% gelatin 
(Sigma, Poole, UK) at 180V for 3-4 hours (buffer 25mM Tris, 190mM glycine, 0.1% SDS).  
A standard of 2000pcg MMP-9 (Merck, Nottingham, UK) was loaded on each gel.  When the 
marker had reached the end of the gel, the gel was washed in 2.5% Triton X for 1 hour, then 
rinsed twice in low salt collagenase buffer (55mM Tris base, 200mM sodium chloride, 5mM 
calcium chloride, 0.02% Brij, pH 7.6) followed by incubation at 37
o
C overnight in 
collagenase buffer.   
Areas of gelatinolytic activity were revealed by a single step stain-destain method using 
0.02% Coomassie Blue (Pharmacia, Sweden) in 1:3:6 acetic acid: methanol: water.  
Densitometric image analysis was performed using Scion Image version 4.0.2.  Gel to gel 
variation can be a major problem with zymography, and so each value was normalised to the 
MMP-9 standard on the gel in order to perform statistical analysis to compare samples 
between gels. Wherever possible, all samples for comparison were run on the same gel to 
minimise this source of variability, and all samples from the same experiment were run 
concurrently. Samples from cell culture experiments were run diluted 1:10 with PBS whereas 
mice samples were run neat. 
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6.14 RNA extraction 
 
For cell culture experiments, PBMCs were added to a 60mm tissue culture dish at 5x10
5
 
cells/cm
2
 in 10% AB serum in RPMI and then infected with Mtb at an MOI of 0.001. After 
72 hours, cells were scraped, pelleted and then re-suspended in 1ml Tri-Reagent (Sigma). 
RNA extraction was performed using the PureLink RNA Mini Kit (Invitrogen, Paisley, UK). 
RNA was extracted by adding 200µl chloroform to each eppendrof tube and shaking 
vigorously for 15 seconds followed by 2-3 minutes incubation at room temperature. After 
centrifugation at 12000g for 15 minutes at 4
o
C, the upper colourless layer (350µl) was 
transferred into an RNase free tube.  
RNA was then precipitated by the addition of 350µl of 70% ethanol. The tube was vortexed, 
and then 700µl of sample was transferred to the spin column and centrifuged at 12000g for 
30 seconds. 350 µL of Wash buffer I was added to the column, followed by centrifugation at 
12 000g for 30 seconds. Thereafter 80 µL of DNase I reaction mixture (8 µl 10 x DNase I 
reaction buffer, 10 µl re-suspended DNase and 62 µl of RNase free water) was added onto 
the column and incubated for 15 minutes at room temperature. 350 µL of Wash Buffer I was 
added to the column which was then spun down, followed by 2 repeated cycles of adding 500 
µL of Wash Buffer II and centrifugation. The membrane on the spin column was dried out by 
spinning down at 12000g for 1 minute and the RNA was then eluted by adding 30μl RNAase 
free water. Total RNA was quantified by spectrophotometry (Nanodrop ND 1000, Thermo 
Scientific). 
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6.15 cDNA Synthesis and Real-time Polymerase Chain Reaction 
 
A volume of RNA equivalent to 1µg was diluted with RNase free water to a volume of 11µl, 
then 1µl random primers was added. Samples were mixed then spun briefly. The sample was 
heated at 65
o
C for 10 minutes, then placed in ice for 1 minute then spun briefly. 8µl master 
mix (4µl 5x 1
st
 strand buffer, 1µl 10mM dNTPs, 1µl DTT, 1µl RNase OUT, 1µl Superscript 
III) was added. The sample was then incubated at 50
o
C for 1 hour followed by 15 minutes 
incubation at 75
o
C. 
Next, the cDNA sample was diluted 1:50 with RNase free water. Standard curves were 
prepared by making 1:5 serial dilutions of one sample to determine accurate quantitative 
changes in RNA levels. 15µl of master mix and 10µl of sample were added to wells, and then 
the plate was spun down at 300g for 5 minutes at 4
o
C before loading onto a Stratagene 
Mx3000P machine.  
RT-PCR cycles initiated with 95°C for 10 minutes followed by 45 cycles of 94°C for 30 
seconds and 60°C for 1 minute. Each MMP result was normalized to 18s level from the same 
sample to control for differences in the amount of total RNA. HEX-labelled GAPDH (Sigma-
Aldrich, Dorset, UK) and VIC-labelled 18S Ribosomal control reagent (Applied Biosystems) 
were analysed in parallel with FAM-labelled MMP-1 and MMP-9 (Sigma-Aldrich, Dorset, 
UK). MMP-1, -7 and MMP-9 primers and probes are described in Table 1. 
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MMP-1 
Forward primer        5’- AAGATGAAAGGTGGACCAACAATT -3’ 
Reverse primer         5’ -CCAAGAGAATGGCCGAGTTC -3’ 
Probe                          5’- FAM-CAGAGAGTACAACTTACATCGTGTTGCGGCTC-TAMRA -3’ 
MMP-7 
Forward primer         5’-CTTTGCGCGAGGAGCTCA -3’ 
Reverse primer          5’-CAGGCGCAAAGGCATGA -3’ 
Probe                           5’- FAM-CCATTTGATGGGCCAGGAAACACG-TAMRA -3’  
MMP-9 
Forward primer         5’- AGGCGCTCATGTACCCTATGTAC -3’ 
Reverse primer         5’- GCCGTGGCTCAGGTTCA -3’ 
Probe                          5’- FAM-CATCCGGCACCTCTATGGTCCTCG -TAMRA -3’ 
Table 1: Sequences of MMP-1, -7 and -9 primers and probes used for gene expression 
PCR studies. 
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6.16 MMP Luminex multiplex Bead Array 
 
Fluorokine Multianalyte Profiling kit is an efficient assay designed for the simultaneous 
detection of multiple analytes in the same sample. Detection is achieved through a bead-
based antibody-antigen sandwich method. Briefly, samples are incubated with colour-coded 
beads that are pre-coated with analyte-specific capture antibodies for the molecule of interest. 
Expression levels are determined after incubation with a biotinylated detection antibody and 
streptavidin-conjugated phycoerythrin (PE). Using a Luminex machine, independent lasers 
determine the colour of each bead to determine the analyte and the magnitude of the PE-
derived signal, which is directly proportional to the levels of bound analyte. 
MMP-1, -2, -3, -7, -8 and -9 concentrations were analysed by Fluorokine multianalyte 
profiling kit on the Luminex platform (Bio-Rad, Hemel Hempstead, U.K.) according to the 
manufacturer’s instructions (R&D Systems, Abingdon, U.K.). Briefly, the recombinant 
standard was reconstituted and then 1:3 serial dilutions were made for a 7 point standard 
curve. The 96-well filter bottom plate was pre-wet with 100µl of wash buffer. 17µl from each 
of MMP beads were diluted with microparticle diluent and 50µl of reconstituted bead mix 
was added into each well. 50µl of standard and samples were then added to the wells and the 
plate was incubated at room temperature for 2 hours on a plate shaker at 500rpm. The plate 
was washed with 100µl of wash buffer three times by vacuum filtration so that the beads 
remained in the wells. Then, 50µl of diluted Biotin Secondary Antibody cocktail was added, 
and the plate was incubated for 1 hour on the shaker followed by another 3 washes steps. 
Then, 50µl of streptavidin-PE was added, incubated for 30 minutes on the shaker again and 
further washed 3 times. The microparticles were resuspended with 80µl of wash buffer, 
incubated for 2 minutes on the shaker at full speed before reading using the Luminex 
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machine. Samples from cell culture and mice lung homogenates were diluted 1 in 5 with 
calibrator diluents while bronchial lavage samples from mice were run neat. 
 
6.17 TIMP Bead Array 
 
TIMPs’ levels in the in vitro granuloma model (IVG) were measured using human TIMP 
panel (R&D Systems, Abingdon, UK) according to the manufacturer’s instructions which are 
essentially similar to the protocol above. An 8 fold standard was prepared with 1:3 serial 
dilutions and samples were diluted 1:50 with calibrator diluents. The panel included TIMP-1 
to -4. 
6.18 Cytokine Bead Array 
 
Cytokine levels were measured using the Cytokine mouse panel (Invitrogen, Paisley, UK) 
according to manufacturer’s protocol which has only minor differences from the protocol 
above. Samples from cell culture and mice lung homogenates were diluted 1 in 5 with assay 
diluent (50/50:  assay diluent/PBS) while bronchial lavage samples from mice were run neat. 
A 9 fold standard was prepared after reconstitution of the provided standard with assay 
diluent. The cytokine panel included EGF, Eotaxin, FGF-basic, G-CSF, GM-CSF, HGF, 
IFN-α, IFN-γ, IL-1ra, IL-1β, IL-2, IL-2r, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12(p40/p70), 
IL-13, IL-15, IL-17, IP-10, MCP-1, MIG, MIP-1α, MIP-1β, RANTES, TNF-α and VEGF. 
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6.19 MMP-1 ELISA  
 
MMP-1 was assayed using the R & D systems Duoset ELISA development system.  Plates 
were coated with 100μl capture antibody (1.0μg/ml) overnight at room temperature then 
washed three times with 0.05% Tween in PBS.  Free binding sites were blocked with 1% 
BSA in PBS for 1 hour and washed three times.  Standards (serial dilutions 10000 pg to 
156.21 pg) and samples (neat, 1 in 5 and 1 in 10) were added to the appropriate wells and 
incubated for 2 hours.  After 3 washes, the detection antibody (100ng/ml) was added for 1 
hour, 3 further washes were performed, and then 100μl streptavidin-HRP was incubated with 
each well for 20 minutes, before washing again.  Colour change was induced by adding 50μl 
substrate solution per well, then the reaction was stopped with 2M sulphuric acid and the 
plate read at 450nm. 
 
6.20 Flow Cytometry 
 
Freshly isolated PBMCs were infected with Mtb at MOI 0.001 and incubated at 37 
o
C for 7 
days. Then, PBMCs were aspirated inside a class II hood and centrifuged at 12000rpm for 8 
minutes then the pellet was resuspended in 1x annexin binding buffer. Annexin V stain (Life 
technologies) was then added, mixed and incubated at dark for 15 minutes. Then, Propidium 
iodide (PI) stain (Life technologies) added to the mix and fluorescence was analysed by flow 
cytometry (BD Accuri™ C6 flow cytometer). 
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6.21 MMPs trapped in matrix 
 
Different matrices were prepared as follows, gelatin matrix (267 μl of 1.5% agar, 100 μl of 
2% gelatin, 100 μl of 10x RPMI, 333 μl dH2O, 100 μl of HEPES and 100 μl of NaHCO3. For 
agar matrix, similar compositions used as for gelatin except that for dH2O the volume 
increased to 433 μl. Alginate was prepared by mixing 500 μl of 1.5% alginate (Sigma, UK), 
100 μl of 10x RPMI, 200 μl dH2O, 100 μl of HEPES and 100 μl of NaHCO3. MMP-1, -2, -3, 
-7, -8 and -9 standards (R&D Systems, Abingdon, U.K.) were mixed with each matrix and 
incubated for 30 minutes before analysed on the Luminex platform (Bio-Rad, Hemel 
Hempstead, U.K.) 
 
6.22 LDH assay 
 
Supernatants from day 3 of the IVG model (described above) were harvested, sterile filtered 
inside the class I hood in the CL3 lab and then transferred to a CL2 lab. 100 µl of the sterile 
supernatant was added into 96 well ELISA plate. Then, 100 µl of reaction mixture from 
Roche (For 100 tests, 250μl of reconstituted catalysis mixed with 11.25ml of dye solution) 
added to each well and incubated at room temperature (protected from light) for 5-30 
minutes. The plate was observed for colour change as a result of the chemical reaction. Then, 
50 µl of stop solution was added to each well and mixed by gently shaking the plate for 10 
seconds and read the plate at 490 or 492nm, with a reference wavelength over 600nm.  
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Average absorbance values of the triplicate samples and controls were calculated, and then 
subtracted from each the absorbance obtained in the background control. The following 
equation was then applied to identify the percentage of cytotoxicity in the samples: 
 
Cytotoxicity (%)  =   exp. value – low control 
                       high control-low control 
 
 
6.23 DQ collagen degradation assay 
 
PBMCs were freshly isolated (as described above) and resuspended in collagen mix solution 
(8 parts sterile collagen type I (Advanced BioMatrix) mixed with DQ collagen (Invitrogen) in 
1:7 ratio, 1 part sterile 10X RPMI, 1 part sterile NaOH in HEPES, 1 part sterile AB serum 
and pH correction as per indicator colour change using sterile 7.5% NaHCO3. 1x10
6
 PBMCs 
were seeded per well in a 4-well cover glass bottom chamber slides (PAA laboratories) in a 
final volume of 1 ml per well and Mtb was added at MOI of 0.001 to infection wells. 
Chamber well slides were incubated at 37
o 
C and 5% CO2 and observed under confocal 
microscope (Leica) at various time points and images were acquired. 
 
X 100 
67 
 
6.24 Green fluorescent collagen degradation assay 
 
Using 4-well cover glass bottom chamber slides (PAA laboratories), 500µl of cold 0.005% 
poly-L-lysine (Sigma) was added to each well and gently agitated for 20 minutes at room 
temperature. Then, poly-L-lysine was removed and washed well gently with 500µl sterile 
PBS. 0.5% glutaraldehyde (BDH) was then added to each well and slides gently agitated for 
15 minutes at room temperature and then washed with sterile PBS. Then, 250µl of collagen-
FITC solution (175µl of Collagen-FITC stock (Sigma, 1mg/ml) with 985 µl 0.1M acetic acid 
solution - protected from light) to each well and gently agitated for 2 hours at room 
temperature.  
Collagen was then removed and wells were washed with sterile PBS. 500µl sodium 
borohydride solution (Sigma) added to each well and gently agitated for 15 minutes at room 
temperature and then washed 5 times with sterile HBSS. Slides were then kept at 4
0
 C 
overnight protected from light. Next day, wells were seeded with PBMCs freshly isolated 
from healthy donor and infected with Mtb as described above. At different time points, slides 
were observed under confocal microscope (Leica) and images were acquired. 
 
6.25 Immunofluorescence and Confocal Imaging 
 
Freshly isolated PBMCs were isolated and infected with Mtb. Control and Mtb-infected cells 
were then mixed with alginate and encapsulated by the bioelectrosprayer into cells containing 
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microspheres inside a class II hood and incubated at 37 
o
C. Microspheres were then fixed in 
4% paraformaldehyde, washed in PBS and then stained with DAPI (4',6-diamidino-2-
phenylindole) or calcineurin. Confocal images were acquired on a Leica SPE microscope 
with an APO 40 X 1.15 NA. oil immersion lens.   
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6.26 Statistical methods 
 
Statistical analysis was performed using GraphPad Prism Version 5.02 for Windows 
(GraphPad Software). Paired groups were compared by the Students t-test, while multiple 
groups were analysed by one-way ANOVA.  Differences were considered significant at a 
value of P < 0.05. 
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7 INVESTIGATING TRANSGENIC EXPRESSION OF HUMAN 
MMPS IN THE MOUSE MODEL OF TB  
7.1 Introduction 
 
It is essential to understand the sequence of events in TB pathogenesis in order to design the 
appropriate prophylactic and therapeutic treatment regimens. TB has remained a global 
pandemic and the first line treatment and vaccination strategies have remained unchanged for 
over 40 years. The hallmark of TB pathogenesis is the formation of granulomas that prevent 
the microbe from further multiplication and spread to other parts of the body. The current 
paradigm is that the immune cells in the centre of granuloma become necrotic and caseate. 
The formed caseous necrosis leads to cavity formation and subsequent TB transmission.  
However, this neglects the fact that lung ECM must be destroyed in order to form cavitation 
and the only enzymes able to cleave ECM fibrils at neutral pH are MMPs. Our group has 
demonstrated that MMP-1 is important in driving pathology in human TB (Elkington et al., 
2011) and  Ramakrishnan’s group have reported that MMP-9 is important in regulating 
monocytes recruitment to the granuloma (Volkman et al., 2010). Finding a suitable model to 
study the role of MMPs in human TB granuloma is therefore necessary to dissect the 
sequence of events in TB pathogenesis.  
The mouse is a valuable model in studying the immune response to Mtb with IFN-γ, TNF-α 
and CD4+ T cells as key players which were first identified in the mouse then confirmed as 
critical regulators of immunity to TB in humans (Cooper, 2009). However, mice can tolerate 
high mycobacterial loads resulting in fibrotic lung pathology without developing 
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multinucleate giant cells (MGCs), caseation or cavity formation (Young, 2009), which 
suggests that mice are deficient in factor (s) of innate immune responses driving 
immunopathology. It is important to note that mice do not express an orthologue of MMP-1 
in the lung. 
Therefore, I first analysed human lung samples from patients with pulmonary TB to study the 
relationship between the caseous necrosis and the integrity of ECM. Then, to develop the 
humanised-MMP mouse model further and to study the role of these enzymes in TB driven 
immunopathology, I infected mice expressing either human MMP-1 or MMP-9 in activated 
macrophages and their wild type littermates.  MMP-9 mice were studied as a control for the 
expression of a human protease and also because MMP-9 has been implicated in cell 
recruitment. Human MMP-1 and MMP-9 enzymes are expressed in the mice under control of 
the scavenger receptor A promotor enhancer. Therefore, under normal circumstances these 
MMPs are not expressed, they are only expressed in activated macrophages.  
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7.2  Experiment design 
 
C57BL/6 Mice were infected intranasally with a virulent clinical Indo-oceanic strain of TB at 
10
4
 CFU's and were followed up for weight loss and distress for 22 weeks and then 
sacrificed. Post-mortem processing was designed to collect the maximum number of readouts 
from each mouse as described in materials and methods chapter. Briefly, the thoracic cavity 
was exposed and an intravenous cannula was inserted into the trachea. A BAL fluid was 
performed with 1ml sterile PBS.  
The left lung was clamped off and divided in two parts. Half was placed in RNAlater for 
mRNA analysis, and half was placed in PBS for protein analysis and colony counting. The 
right lung was then inflated with formalin for 5 minutes under 20cm pressure using an 
intravenous giving set attached the cannula. The lung was then immersed in formalin for 24 
hours then was embedded in paraffin and serial 3µm sections were then taken of the whole 
lung.  Sections were stained with Haematoxylin and Eosin. Collagen and ECM were stained 
with Picrosirius red and Masson’s Trichrome, respectively. 
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7.3 Results 
 
7.3.1 Lung matrix destruction and caseous necrosis co-localise in human 
pulmonary TB granulomas. 
First, I investigated ECM integrity and caseous necrosis in lung granulomas from patients 
with pulmonary TB (Figure 5). Lung biopsies from patients under investigation for probable 
lung cancer who had a final diagnosis of pulmonary TB were studied. To characterise the 
total ECM components, I stained lung sections with Masson’s Trichrome (MT). MT stain can 
be used in various applications, differentiating cells from adjacent connective tissue. 
Generally, MT consists of nuclear, collagenous and cytoplasmic dyes that stains black, 
green/blue and red, respectively.  
 MT staining showed that the ECM was intact where cells were viable, whereas in areas of 
caseous necrosis no ECM was visualised. Furthermore, lung sections were stained with Sirius 
red which is one of the best understood techniques of collagen histochemistry that exploits 
the enhancement by Sirius red of the birefringence of collagen fibres, which is largely due to 
co-aligned molecules of type I collagen. Under light microscopy, it stains collagen in red on a 
pale yellow background. Staining with Sirius red showed that collagen was intact in areas 
where immune cells are viable and ECM is still intact. However, the collagen red staining 
was absent in areas of caseous necrosis.  
To confirm this observation, I stained the sections with Elastin van Giesen (EVG) that stains 
another component of the ECM; Elastin, in green/blue colour. The EVG staining 
demonstrated that elastin was absent in these caseous necrosis regions. Therefore, in patients 
with active pulmonary TB, caseous necrosis and ECM destruction are observed concurrently, 
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but whether cell death or matrix destruction is the initial pathological event cannot be 
determined. 
To address the relationship between cell death and matrix destruction, I used the MMP-
humanised mouse model and infected the mice with a virulent clinical strain of Mtb isolated 
from a patient with pulmonary TB. Mice expressing human MMP-9 regulated by the same 
promoter acted as controls for the transgenic expression of a human MMP. 
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Figure 5: Lung matrix destruction and caseous necrosis co-localise in human 
pulmonary granulomas. 
I investigated ECM integrity and caseous necrosis in lung granulomas from patients with 
pulmonary TB. MT staining, where ECM stains green, showed that the ECM was intact 
where cells were viable, whereas in areas of caseous necrosis (arrow heads) no ECM was 
visualised. Similarly, Sirius red staining showed collagen was absent in areas of caseous 
necrosis (arrow heads) and EVG staining demonstrated no elastin, which stains blue, was 
present in these regions (arrow heads). In all regions of caseous necrosis, ECM is absent.  
Scale bars 100μm. Representative images of lung sections from 6 patients with pulmonary 
TB are shown. 
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7.3.2 Genotyping transgenic mouse colonies 
C57BL/6 mice expressing either human MMP-1 or -9 were generated by Dr Jeanine 
D’Armiento, Columbia University, New York, and were provided as part of an ongoing 
collaboration between our groups. Mice are bred in the animal facility in CBS at South 
Kensington. Initially, I encountered a problem with genotyping MMP-1 mice as there were 
only few of them showed bands in the agarose gel (figure 6A). 
This problem could have resulted from the primers used, background contamination of the 
DNA or the long product of the PCR. I optimised the MMP-1 mice genotyping PCR by 
various approaches such as using lower DNA concentrations, different set of primers, more 
concentrations of dNTPs and primers and running more cycles of the PCR.  The key 
optimisation was increasing the dNTPs concentration which resulted in much more consistent 
genotyping (figure 6B). 
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A) 
 
           B) 
 
 
Figure 6: Genotyping PCR of MMP-1 mice. 
An agarose gel showing: A) Single positive band at 800bp and then, B) multiple positive 
bands after optimising the PCR conditions. 
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7.3.3 Mouse weight did not significantly differ between strains after infection 
with Mtb 
 
TB infection is usually accompanied by weight loss in man and in mice experiments, is used 
to monitor severity of infection over time.  Indeed, our Home Office licence stipulated that if 
greater than 20% weight loss occurred, mice should be sacrificed.  Therefore, after infection 
with TB, mice were followed up regularly (weekly for the first 4 weeks and fortnightly 
thereafter) for signs of distress and weight loss. Wild type (WT) and MMP-1 and MMP-9 
transgenic mice showed no significant difference in weight loss throughout the 22 weeks 
course of the experiment (figure 7).  
In each of the three experiments carried out, 1-2 Mtb infected mice didn’t tolerate the 
infection and showed significant weight loss (more than 20% weight loss) during the first few 
weeks of the experiment. Therefore, these mice were excluded as they were needed to be 
culled according to the Home Office regulations of the animal welfare.  Our hypothesis is that 
in these mice, the intranasal infection was breathed in bilaterally by the mice and therefore 
caused extensive pneumonia and systemic illness, whereas in most mice initial infection was 
unilateral and localised.  No difference between the mouse strains in terms of early mortality 
was noted. 
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Figure 7: Weight chart of WT, MMP-1 and -9 mice. 
Following Home Office regulations, mice were weighed regularly to exclude mice that lost 
more than 20% of weight. The chart showed no difference among the three groups of mice 
throughout the 22 weeks course of the infection experiment. Data are from 3 separate 
experiments, with 19 WT, 16 MMP-1 and 15 MMP-9 mice studied in total. Error bars = 
standard deviation. 
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7.3.4 No difference in mycobacterial growth was observed between mice 
strains 
After 22 weeks of infection, mice were sacrificed by terminal overdose of anaesthetic and 
dissected as described in the materials and methods chapter. Colony counting was performed 
by plating serial 1:10 dilutions of lungs’ homogenates on Middlebrook 7H11 agar and 
colonies were counted after 3 weeks of incubation at 37°C. Expression of human MMP-1 and 
-9 enzymes didn’t alter the control of mycobacterial growth in the lungs. There was no 
significant difference in mycobacterial burden among all the three strains of mice in all the 
three experiments (figure 8). This suggests that genetic background of these mice had no 
influence on lung mycobacterial burden in the latent stage of the infection.  
 
7.3.5 Mtb infection up-regulated human MMP-1 and MMP-9 expression in 
the respective transgenic mice 
To check that the MMPs were being upregulated by TB infection in the respective mice 
strains, I measured the MMP concentrations in the lung homogenates of humanised 
transgenic mice and wild type mice by Luminex, calibrating the machine at high sensitivity 
as measuring MMPs in homogenised tissue has been technically challenging (figure 9). 
MMP-1 was hardly detectable in the uninfected MMP-1 transgenic mice, but very high in 
infected ones; confirming that infection was upregulating MMP-1 enzyme. Similarly, MMP-9 
was only elevated in the infected MMP-9 transgenic mice. This also confirms the genetic 
background of the humanised transgenic mice and demonstrated that activation of the 
scavenger receptor A promoter was driving MMP expression. 
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Figure 8: Colony counts in WT, MMP-1 and MMP-9 mice infected with TB. 
After 22 weeks of infection, mice were sacrificed lungs were dissected off and homogenised. 
Mycobacterial load in lung homogenates of the three genetic backgrounds mice showed no 
significant difference. Data are from 3 separate experiments, with 19 WT, 16 MMP-1 and 15 
MMP-9 mice studied in total. Error bars = standard deviation. 
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Figure 9: Concentrations of MMPs in the lung homogenates of the transgenic mice. 
The increased secretion of MMPs in the lung homogenates of infected mice showed that 
infection was upregulating MMP enzyme. MMP-1 and MMP-9 enzymes were only elevated 
in humanised transgenic MMP-1 and MMP-9 mice respectively. Data are from 3 separate 
experiments, with 19 WT, 16 MMP-1 and 15 MMP-9 mice studied in total. Error bars = 
standard deviation. 
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7.3.6 Multinucleated giant cells were observed in all Mtb-infected mice strains 
MGCs have been considered as significant hallmarks of chronic inflammatory responses 
formed by the union of immune cells (macrophages). It can arise in response to an infection, 
such as from tuberculosis, herpes, or HIV, or foreign bodies. In TB and many types of 
granulomatous diseases, the epithelioid macrophages fuse together and in return multiple 
nuclei form a circle or semicircle related to the shape of a horseshoe away from the centre of 
the cell. However, it is still not fully understood why these reactions occur and what their 
roles in such conditions are. 
Lung sections of the TB infected mice were stained with H&E and revealed the presence of 
MGCs in areas of macrophage infiltration in WT, MMP-1 and MMP-9 mice (figure 10). 
These are cells with large central cytoplasm ringed by multiple nuclei and are derived from 
macrophages.  The cytoplasm stained bright pink with H&E and therefore the MGCs were 
relatively easy to visualise within infected tissue.  However, the presence of MGCs in mice 
infected with TB is not generally reported in the literature (Russell et al., 2010, Rhoades et 
al., 1997). Therefore, this suggests that this was a feature of a virulence strain of Mtb but as 
MGCs occurred in all mice strains, were not the effect of the genetic background of these 
mice. 
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Figure 10:  MGC formation in lung sections of WT, MMP-1 and MMP-9 mice. 
Mice infected with a virulent Indo-oceanic strain of Mtb showed the presence of MGCs 
(arrowheads) in areas of infection in the lungs of WT (A), MMP-1 (B) and MMP-9 (C) mice. 
The presence of MGCs in mice infected with Mtb is not widely reported in the literature. 
Scale bars 100μm. Representative images from 3 independent experiments with a total of 50 
mice are shown. 
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7.3.7 MMP-1 expressing mice showed areas of caseous necrosis in Mtb-
infected lungs 
Caseous necrosis is the pathological hallmark of human TB.  It derives its name from the 
cheese-like appearance of central necrosis in TB granulomas where the dead tissue appears as 
a soft and white proteinaceous dead cell mass.  It has been reported in primate, rabbit and 
guinea pig models of TB, but not in the mouse model of TB (Young, 2009).   
H&E staining of lung sections showed the typical appearance of TB infected lungs in WT 
mice consisting of areas of inflammatory infiltration and foamy macrophages but the alveolar 
wall structure is intact (figure 11A and B). However, lung sections of MMP-1 expressing 
mice revealed areas of infection characterise of an amorphous matter consisting of cellular 
debris and absent alveolar wall structure which is consistent with caseous necrosis (figure 
11C and D). These changes were obvious even in small lesions only in MMP-1 mice but not 
WT or MMP-9 (figure 11E and F). The only difference between WT and MMP-1 mice is the 
expression of MMP-1 enzyme in the activated macrophages in the lungs of MMP-1 
transgenic mice. 
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Figure 11: MMP-1 mice develop caseous necrosis within infected granulomas. 
Images of light microscopy show characteristic features of TB infection in WT mice 
consisting of areas of inflammatory infiltration and foamy macrophages but the alveolar wall 
structure is intact (A and B). MMP-1 expressing mice show an amorphous matter (arrow 
heads) consisting of cellular debris and absent alveolar wall structure (C and D). These 
changes are not seen in MMP-9 mice (E and F).  Scale bars 25μm. Representative images 
from 3 independent experiments with a total of 50 mice are shown.  
87 
 
7.3.8 Mouse lung pathology was correlated with lung mycobacterial load 
Although mice have no significant differences in lung mycobacterial load among WT, MMP-
1 and MMP-9 mice, there were differences in the extent of infection between individual mice. 
Therefore, to develop a more quantitative readout of the extent of lung involvement, H&E 
slides of mouse lung sections were examined to score the degree of the infection with the 
naked eye in the lung on a scale of 0 – 10.   
The extent of infiltration was then correlated with the CFUs in lung homogenates (figure 12). 
The more extensive lung pathology was observed in the lungs of mice infected with higher 
loads of mycobacteria. Furthermore, I measured the granuloma sizes using digital image 
analysis software (Hamamatsu Nanozoomer) and calculated the percentages of affected area. 
The result was consistent with my previous scoring system as more involvement of the 
pulmonary disease was seen in mice with higher bacterial burden (data not shown).  
Therefore, the greater the mycobacterial load, the greater the gross inflammation, but this did 
not differ between strains. 
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Figure 12: Correlation of mycobacterial burden in lung homogenate with histology 
score of macroscopic lung pathology on H&E slides. 
The lung CFUs of all infected mice were positively correlated with a macroscopic histology 
score (0-10) of the extent of lung pathology estimated blindly by two different assessors. 
Data from 3 independent experiments with a total of 50 mice are shown. Error bars = 
standard deviation. **** P < 0.0001. Correlation test was performed. 
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7.3.9 Increased bacterial burden was associated with increased levels of 
MMPs 
I have shown in figure 9 that TB infection was upregulating MMPs in the infected lungs of 
the transgenic mice. Consequently, I wanted to examine the relationship between the 
mycobacterial burden and the concentrations of the MMPs secreted in the infected lungs 
(figure 13). I found that more CFUs of Mtb was associated with increased concentrations of 
the MMP-1 and MMP-9 in the infected lungs of the transgenic mice, demonstrating that a 
higher infectious burden drove higher MMP expression. 
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Figure 13: Correlation of mycobacterial burden with MMP concentrations in lung 
homogenates of infected mice. 
Concentrations of MMPs in lung homogenates of infected mice correlate positively with lung 
CFUs in both MMP-1 and MMP-9 expressing mice Data are from 3 separate experiments, 
with 16 MMP-1 and 15 MMP-9 mice studied in total. Error bars = standard deviation.* 
P<0.05, **** P<0.0001. Correlation test was performed. 
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7.3.10 MT stain revealed matrix breakdown in areas of necrosis 
I have shown that in human lung sections, ECM was destroyed in areas of caseous necrosis 
but which event happened first could not be assessed. To try to investigate this relationship 
further, in this humanised mouse model, I stained mouse lung sections with MT to study the 
integrity of ECM after 22weeks infection with a virulent strain of Mtb. 
The uninfected WT mice showed the normal distribution of the blue-stained ECM in the 
lung. In MMP-1 mice, however, the ECM was destroyed in areas of caseous necrosis as 
demonstrated by the loss of the MT blue staining in these areas (figure 14). However, ECM is 
intact in Mtb-infected lungs of WT and MMP-9 mice where cells are viable and ECM is 
stained blue.  
Therefore, MT staining demonstrate that in MMP-1 expressing mice ECM is lost where cells 
are dead but in WT and MMP-9 expressing mice live cells where associated with preserved 
ECM. Because lung sections stained with MT showed relatively low resolution and to further 
confirm this significant observation, I decided to stain sections with Sirius red. 
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Figure 14: Light microscopy of MT stain of lung sections of mice infected with Mtb. 
WT (uninfected) mice showed the normal distribution of the blue/green MT that stains the 
ECM. Infected WT showed the cellular infiltrates had no significant difference on MT stain. 
However, in MMP-1 expressing mice, the ECM is destroyed in areas of caseous necrosis as 
demonstrated by loss of MT stain (arrow heads). MMP-9 mice showed no difference in MT 
stain to WT mice (x20 magnification). Representative images from 3 independent 
experiments with a total of 50 mice are shown.  
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7.3.11 Picosirius Red staining confirms the co-localization of caseous necrosis 
and matrix destruction 
 
Sirius red stains collagen in red on a pale yellow background. I stained uninfected mice lung 
sections which showed the normal architecture of the collagen distribution in the alveolar 
walls (figure 15), as has previously been described in Mtb-infected mice (North and Jung, 
2004). WT and MMP-9 mice infected with Mtb showed no significant difference to normal 
collagen staining in areas of infection to WT mice. MMP-1, on the other hand, revealed loss 
of collagen fibres in the ECM in areas of caseous necrosis.  
Sirius red staining confirms the phenomenon of concurrence of collagen destruction in areas 
where cells were dead which has been observed in lung sections stained with MT. The loss of 
collagen fibres demonstrates the collagenolytic activity of the MMP-1 transgenically 
expressed in this group of mice. Therefore, I decided to examine procollagen PIIINP which is 
a matrix degradation product to further confirm the matrix breakdown in the lungs of Mtb-
infected mice. 
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Figure 15: Sirius red (SR) stain demonstrating absent collagen within caseous TB 
granulomas. 
Collagen fibres appear red under light microscopy when stained with SR. the collagen fibers 
can be seen intact in the lung sections of WT and MMP-9 mice. However, MMP-1 mice 
showed a remarkable destruction of collagen as demonstrated by loss the stain in areas of 
caseous necrosis (arrow heads). Scale bars 100µm. Representative images from 3 
independent experiments with a total of 50 mice are shown. 
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7.3.12 Procollagen III N-terminal Propeptide (PIIINP) is elevated in Mtb-
infected mice 
Immunoreactive peptides are released from intact collagen fibrils due to the proteolytic 
activity of collagenases that cause ECM destruction (Lopez et al., 2010). PIIINP is the amino 
terminal peptide of type III procollagen, released from the precursor peptide during the 
synthesis and deposition of type III collagen. 
I examined PIIINP in the lung homogenate of uninfected and Mtb-infected mice using 
ELISA as a read out (figure 16). The three different genetic background mice showed 
comparable levels of PIIINP in their lungs when they are not infected with TB. However, all 
Mtb-infected mice showed increased levels of PIIINP in the lung homogenate compared to 
control mice. Although not statistically significant, there is a trend towards an increase in 
collagen turnover in lung homogenate of MMP-1 mice compared to WT and MMP-9 mice. 
This suggests that Mtb infection causes lung tissue destruction demonstrated by an increased 
level of Matrix Degradation Product (MDP) in the infected mouse lung, but that greater 
number of mice would be needed to study this phenomenon.  It is interesting to note that 
PIIINP was also elevated in the mice that did not express MMP-1.  
I have shown that Mtb infection causes MMP-1 upregulation which lead to collagen 
destruction and that destruction was associated with caseous necrosis. I have also shown that 
there was no significant difference in lung mycobacterial load in the three groups of mice. 
My next step was to test that whether the difference in lung pathology was due to the effect of 
MMPs activity or because of changes in immunological mediators. Therefore, I decided to 
profile cytokines and chemokines in this mouse model. 
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Figure 16: PIIINP concentration in lung homogenates of Mtb-infected mice. 
PIIINP, amino terminal peptide of type III procollagen, is a collagen degradation product. 
Lung homogenates of WT, MMP-1 and MMP-9 mice showed increased levels of PIIINP 
more than that in the respective control. Data are from 3 separate experiments, with 19 WT, 
16 MMP-1 and 15 MMP-9 mice studied in total. Error bars = standard deviation.  
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7.3.13 MMP expression did not alter the immunological parameters in the 
mouse model 
After demonstrating that Mtb infected mice induced MMP-1 and -9 gene expression and 
secretion which resulted in different lung pathology, next I attempted to profiled cytokine, 
chemokine and growth factors response in Mtb-infected mice’s lung homogenates and BAL 
fluid. 
Based on cytokine profile, T cells may be divided into two main different subsets; Th1 cells 
producing IL-12, IL-1β and IFN-γ and Th2 cells producing IL-4, IL-5 and IL-10. Generally, 
Th1 cells are associated mainly with cellular immunity while Th2 cells are associated with 
humoral immunity. It has been postulated that caseous necrosis results from an imbalance in 
TH1/TH2 immunity (Dheda et al., 2005).  
In lung homogenate and BAL fluid of Mtb-infected mice, IL-12, IL-1β and IFN-γ were 
elevated in WT, MMP-1 and MMP-9 mice compared to uninfected mice.  However, no 
significant differences were observed amongst the three groups of infected mice (figure 17). 
On the other hand, IL-4 concentrations were comparable in both Mtb-infected and control 
WT, MMP-1 and MMP-9 mice. Also, I profiled chemokines in the mouse model and found 
IP-10, MIG and MCP-1 were higher in infected WT, MMP-1 and MMP-9 mice compared to 
the uninfected mice.  The only chemokine which was unchanged was IL-8 (KC), where no 
difference between infected and uninfected mice was observed (figure 18).   
The similar profile of the immunological mediators in this mouse model, in addition to the 
similar mycobacterial growth pattern, suggest that lung pathology that was observed (caseous 
necrosis in areas of matrix destruction) was an effect of the collagenase MMP-1 as it is the 
only difference between the MMP-1 and WT mice. 
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Figure 17: Cytokine concentrations in lung homogenates of Mtb infected mice. 
Concentrations of IL-12, IL-1β, IFN-γ and IL-4 were measured in mouse lung homogenates 
after 22 weeks course of Mtb infection by Luminex array. Mtb infection up-regulated Th1 
cytokines (IL-12, IL-1β and IFN-γ) in all mouse strains, but there were no significant 
differences related to the genotype of the mouse. Th2 cytokine IL-4 levels showed no 
significant differences between infected and uninfected mice of the three genetic 
backgrounds. Data are from 3 separate experiments, with 19 WT, 16 MMP-1 and 15 MMP-9 
mice studied in total. Error bars = standard deviation. 
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Figure 18: Chemokine concentrations in lung homogenates of Mtb infected mice. 
Mtb infected mice showed higher concentrations of IP-10, MIG and MCP-1 in the lung 
homogenates compared to control mice except for IL-8 (KC) which was comparable among 
all mouse strains. Data are from 3 separate experiments, with 19 WT, 16 MMP-1 and 15 
MMP-9 mice studied in total. Error bars = standard deviation. 
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7.3.14 Mtb bacilli are observed in the infected lungs of the mice. 
I have shown that Mtb infection of the lungs of transgenic mice caused human-like lung 
pathology; therefore my next step was to confirm the presence of the causative agents within 
lung lesions. I stained lung sections of the mice with Ziehl–Neelsen (the acid-fast) stain 
which is mainly used to identify Mtb (figure 19). Under light microscopy, Mtb bacilli appear 
as bright red (arrows) in areas of macrophage infiltration in WT, MMP-1 and MMP-9 mice 
infected with TB. 
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Figure 19: Mtb bacilli in the infected lungs of the mice. 
Lung sections of WT, MMP1 and -9 mice were stained with Ziehl-Neelsen (acid fast) stain 
that stain Mtb bacilli in bright red colour. Acid fast bacilli (arrows) are present in areas of 
foamy macrophage infiltration in lungs of infected mice. Original magnification x100, scale 
bar 20μm. Representative images from 3 independent experiments with a total of 50 mice are 
shown. 
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7.4 Discussion 
 
I have examined the relationship between lung ECM and caseous necrosis in lung sections of 
patients with pulmonary TB and observed the co-localisation of matrix destruction and 
caseous necrosis. This relationship was further investigated to identify the sequence of these 
two events using MMP-humanised mouse model. Transgenic mice expressing human MMP-
1 and -9 in activated macrophages have shown an increased level of the corresponding MMP 
after 22 weeks infection with virulent strain of Mtb. Post-mortem processing was designed to 
collect the maximum number of readouts from each mouse as described in materials and 
methods. 
MGCs were observed in lung sections of all the infected mice suggesting that this a feature of 
virulence strain of Mtb rather than the genetic background of the experimental mice. 
However, caseous necrosis was observed in TB granulomas of humanised-MMP-1 mice only. 
It is important to highlight the fact that the only difference between MMP-1 and WT mice is 
the expression of the human collagenase (MMP-1) in their activated macrophages. To test 
this hypothesis, that it was collagenase activity, as opposed to an immunological imbalance, 
ECM staining was performed and cytokines were measured in the lung homogenates of the 
Mtb infected mice. I found that there was no significant difference between the mice strains 
in cytokine profile. In addition, mycobacterial lung burden was comparable in WT, MMP-1 
and MMP-9 mice which further confirm that histopathological changes observed were not 
due to difference in immunological mediators or Mtb growth. Staining ECM components 
revealed the breakdown of ECM in areas of caseous necrosis. Viable cells can be observed in 
Mtb infected lungs where ECM is intact. I found that PIIINP, an ECM degradation product, 
was elevated in the lung homogenates and BAL fluid of all the infected mice compared to the 
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uninfected mice, suggesting that other proteases in addition to MMP-1 are contributing to 
lung tissue destruction and turnover of type III collagen. 
Although there are various animal models of TB, finding a suitable animal model 
representing human pathology in TB is challenging. The non-human primates may best 
reproduce human phenomena when infected with TB but they are expensive and involve 
logistic difficulties (Lin et al., 2006). Rabbits develop a more human-like granuloma structure 
with central caseous necrosis and cavity formation (Dannenberg and Sugimoto, 1976). 
Although rabbits could be handled easier than the non-human primates, there are less 
immunological tools in the research field to assess in generating various readouts when used 
in TB experiments.  
On the other hand, the mouse is the most frequently used model in TB with advantages of 
similar immune response to human TB, such as key roles for IFN-γ, TNF-α and CD4+ T cells 
in regulating the immune response. The availability of a wide range of chemicals and 
reagents as well as the ability to modulate specific genes and alter genetic background add 
more advantages to the mouse model and make it widely used in TB research. However, TB-
infected mice develop diffuse cellular infiltration and fibrotic lung lesions with poorly 
structured granulomas that do not form caseation or cavitation (Helke et al., 2006). Well-
structured granulomas and caseous necrosis can be seen in guinea pigs but they form a 
fulminant response and die rapidly. One model where widespread tissue necrosis in the 
mouse has been reported (Kranmick), but these mice are immunocompromised and have a 
very high mycobacterial load, whereas in human disease mycobacteria are scanty within the 
granuloma (Pan et al., 2005). 
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MGCs are formed by fusion of PBMCs during inflammatory reactions and involved in 
granuloma formation in TB, foreign body and other granulomatous lesions (Adams, 1976). 
MGCs are thought to play important roles in host defence mechanisms (Kaufmann, 1993) and 
their absence in associated with inadequate immune response to TB (Jagadha et al., 1985). 
However, the mechanism of MGCs formation is still not understood (Chambers, 1978).  
There are different Mtb strains being used in TB research, the most commonly used is the 
H37Rv. Our group has previously shown that infecting MMP-humanised mouse with H37Rv 
stain did not cause caseous necrosis in the infected lungs. A likely explanation is the 
attenuation of the microbe as the strain has been subjected to repeated subculturing process 
over many decades which may have rendered the strain with weak virulence. Therefore, the 
appearance of MGCs in our current studies would suggest that they result from fully virulent 
Mtb, not laboratory-adapted strains, and the development of caseous necrosis requires both a 
virulent strain and expression of the collagenase MMP-1.  Consistent with this, it has been 
demonstrated that different Mtb strains can cause diverse pathology on rabbits (Manabe et al., 
2003). Lung lesions in rabbits infected with H37Rv were healed earlier than those infected 
with the Erdman strain. 
The principal elements of the immune response to Mtb  in humans (IFN-γ, TNF-α and CD4+ 
T cells) were first identified in mice (Cooper, 2009). In the mouse model I used, there was no 
difference in these immunological mediators between the WT and the humanised transgenic 
mice. Therefore, it would seem that the histological difference observed were not due to 
differences in the immunological profile between mice strains.  The only difference was the 
expression of human metalloproteinase in the activated macrophages of the respective mouse 
group.  
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Lung ECM plays important roles in different physiological conditions such as morphogenesis 
and wound healing in addition to being critical physical scaffold for the surrounding cellular 
structure. Excessive ECM breakdown is associated with pathological conditions like 
Rheumatoid Arthritis and sarcoidosis (Parks et al., 2004). The fact that caseous necrosis 
observed in areas of macrophage infiltration in the infected lung of MMP-1 mice only 
indicate that ECM destruction may be the cause of cell death, as opposed to the result of it as 
suggested by the current paradigm of TB pathogenesis. 
The ECM has been described as a cell survival factor in other pathological conditions, such 
as cancer (Meredith et al., 1993). It has been thought that the formation of caseous necrosis 
leads to tissue destruction and subsequent cavity formation and transmission. However, this 
paradigm neglects the fact that ECM must be degraded before forming the cavity and that 
MMPs are the only enzymes capable of degrading all components of ECM at neutral pH. 
Therefore, I would propose a different paradigm of TB pathogenesis, starting with granuloma 
formation which induces MMP-1 upregulation that in turn cause ECM destruction, leading to 
cell death, as cells lose survival signal from ECM, and ultimately to cavity formation.   
A central role for matrix destruction in regulating cellular behaviour has widespread 
implications for TB research. Cell-matrix interactions may affect phagolysosomal fusion 
(Mills and Frausto, 1997), pro-inflammatory cytokine secretion (Coyne and Dervan, 1997), 
autophagy (Kuratani et al., 1998) and immune cell activation (Sorokin, 2010), all critical 
processes in the immune response to TB. Tissue damage is emerging as a central determinant 
of the outcome of the host-pathogen interaction in other lung infections, such as bacterial-
viral co-infection (Salamanca et al., 2002), supporting the hypothesis that preserving matrix 
integrity is fundamental to an effective response to infection. 
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To conclude, the humanised mouse model has revealed that interfering with ECM integrity 
by MMP-1-induced lung tissue destruction causes caseous necrosis which is not seen in any 
other immune competent mouse model. This suggests that ECM destruction is the first step in 
TB immunopathogenesis, as opposed to a secondary result of cell death as currently 
postulated. To study this finding further, I examined the effect of ECM on cells infected with 
Mtb in cell culture systems.  
  
107 
 
8 DEFINING MMPS ACTIVITY IN A STANDARD 
GRANULOMA MODEL OF TB 
 
8.1 Introduction  
 
I have shown in the previous chapter studying MMP humanised mice that ECM integrity 
appears to be an important factor in cell survival, as areas of caseous necrosis were associated 
with matrix breakdown. Also, I have shown that MMP-1 was the effector enzyme causing 
tissue destruction in mouse lungs infected with Mtb. My mouse model revealed the 
significant findings on lung histology after long term Mtb infection experiments. However, 
the mouse model does not allow detailed monitoring of the early stages in TB infection and 
the progressive formation of granuloma structure with the initial cell-cell interactions. 
To study the initial events in granuloma formation and the role of MMPs, I adapted an in 
vitro granuloma model developed by Altare’s group who used both mycobacterial antigens 
coated on spheroid beads and live mycobacteria incubated with PBMCs and monitored for up 
to 21 days (Puissegur et al., 2004, Puissegur et al., 2007, Russell et al., 2009, Lay et al., 
2007). The model showed the typical progressive recruitment of macrophages surrounding 
the Mtb or Mtb antigens and the development into epithelioid cells and MGCs, mimicking 
the natural occurring granuloma. This IVG model has the potential to monitor the 
development of the Mtb-induced granuloma formation and to explore the role of MMPs in 
this process, though to my knowledge MMPs have not been investigated in this model 
system.  
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The IVG model can also be utilised to incorporate ECM into the PBMCs and study the cell-
matrix interaction. ECM has various nature and structures depending on organ type, 
therefore, it has several roles, including providing physical support to cells, separating tissues 
from each other, and regulating intercellular communication (McGowan, 1992). Furthermore, 
in ductal epithelial tissues, cell-matrix interaction leads to form a molecular structure within 
the ECM critical for mechanical buffering so that growth factors are easily accessible from 
ECM repository (Iozzo and Murdoch, 1996). Collagen is the most abundant protein in the 
ECM and plays important roles as scaffolding (Di Lullo et al., 2002) and regulating cell 
adhesion, enhancing migration and chemotaxis, and directing tissue development (Rozario 
and DeSimone, 2010).  
MMP-1 has been shown to breakdown ECM and lead to lung tissue destruction in the MMP-
humanised mouse model when infected with the standard laboratory H37Rv strain of Mtb 
(Elkington et al., 2011). However, the relationship between ECM degradation and cell 
behaviour in cells infected with Mtb has not been fully investigated yet. Therefore, I 
developed an in vitro model of TB granuloma to study the granuloma formation and the role 
of MMPs in this model as a stepping stone to investigate the role of ECM in regulating the 
behaviour of Mtb-infected immune cells. 
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8.2 Results  
8.2.1 Developing an in vitro granuloma model of TB 
 
In order to introduce the IVG developed by Altare to the laboratory for the analysis of MMPs 
in granuloma formation (Puissegur et al., 2004, Puissegur et al., 2007, Lay et al., 2007). I 
performed eleven initial characterisation experiments with various experimental conditions to 
optimise the model. Variables studied in the initial experiments were the percentage of 
human AB serum, the infective MOI and the tissue culture plastic used. In a 24 well plate, I 
cultured 1x10
6
 PBMCs per well then infected them with Mtb at MOI ranging from 0.1 to 
0.00001. Infecting cells with MOI of less than 0.001 was associated with poor granuloma 
structure. On the other hand, infecting cells with MOI of more than 0.001 was shown to be 
too virulent as the high initial bacillary number led to the formation of clumps and significant 
floating dead cells were observed.  
I have also performed the experiment on chamber well slides where I cultured 9x10
5
 PBMCs, 
which corresponded to 5x10
5
 cells per cm
2
, and infected them with similar MOI which 
showed similar cellular aggregation. Also, I have tried different concentrations (5% and 10%) 
of human AB serum and found that 10% AB serum was optimal for cell survival. Therefore, 
from these optimisation experiments, I concluded that infecting PBMCs (supplemented with 
1ml of 10% AB serum in RPMI) with an MOI of 0.001 was found to provide the most 
consistent method for developing granuloma-like structures.  
Cells were observed daily under light microscopy for two weeks and at time points of day 0, 
3, 7, 11 and 15 supernatants were harvested and images were acquired (figure 20A). At day 0, 
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there were no clumps of cells observed, and then by day four there were small clumps of cells 
around Mtb that were not observed in uninfected wells. By day seven the clumps of cells 
became larger and then they were beginning to disperse by day 14 when dense aggregates of 
bacterial growth became apparent in the centre of the granuloma structure. There appeared to 
be large clumps of TB centrally with peripheral macrophages and T cells (figure 20B, arrow). 
PBMCs were stained with CellTracker™ green that stains cytoplasm in green fluorescence 
and observed cellular aggregates at day 7 (figure 21). Confocal images revealed the presence 
of immune cells of different populations in the formed granuloma structure. 
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      Figure 20 continues … 
A. 
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         Figure 20 continues … 
113 
 
 
 
 
 
 
Figure 20: Mtb infected PBMCs showing cellular aggregations. 
A) PBMCs are mixed with Mtb at MOI of 0.001 and observed under inverted light 
microscope for two weeks. No aggregates were seen at day 1 but at day 4 cells started to 
surround Mtb and then by day 11 clumps of cells (arrows) started to appear. B) High 
resolution of images from TB infected wells at days 7 and 15. Scale bars 100μm. Images are 
representative of a total of 11 different optimisation experiments. 
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Figure 21: Confocal images showing cellular aggregations formed of different 
populations. 
PBMCs, stained with CellTracker green showed cellular aggregates at day 7 after infection 
with Mtb. Activated macrophages (arrowhead) are observed at the centre of the lesion and 
with T lymphocytes around them (arrow). Images are representative of 7 confocal 
experiments. 
 
 
 
115 
 
8.2.2 MMP secretion in the IVG model  
In order to investigate whether MMPs were upregulated in this in vitro granuloma model, 
first I profiled the accumulation of MMPs in the cell culture supernatant overtime by 
Luminex multiplex array. PBMCs secrete several MMPs in response to Mtb. PBMCs were 
infected with Mtb at MOI 0.001 and supernatants were harvested at different time points 
throughout the 15 days course of experiment. 
 I have done three different blood donors (figure 22A-C) and then I pooled data from these 
donors in one graph (figure 22D) I observed some variations between donors as expected 
with work with primary human cells. However, in all cases, TB infection upregulated key 
MMPs. The variability was in the peak concentrations reached in infected cells. For example, 
one donor achieved 208pg/ml of MMP-1 while another achieved 689pg/ml.  
TB-infected PBMCs secrete greater MMP-1, -7, -8 and -9 than uninfected cells. On average, 
MMP-1 was increased 10.6 fold at day four, MMP-7 was increased 78.6 fold, MMP-8 was 
increased 1.4 fold and MMP-9 was increased 8.9 fold. The concentration of MMP-9 was the 
highest of the all proteases. 
The MMP-9 concentration increased with time and its secretion from TB-infected PBMCs 
was much more than that secreted from uninfected cells. However, at the final stages of the 
experiment, the concentration of MMP-9 in the uninfected cells increased, which potentially 
could be because of cell death at this stage. MMP-2 and -3 concentration was no different to 
control samples and the high initial MMP-2 concentration was thought to be due to the 
MMPs already present in the human serum, as the concentrations were high at day 0, but no 
increased secretion occurred over time. 
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Figure 22: Mtb infection induces MMP secretion from PBMCs. 
PBMCs infected with Mtb secrete more MMPs than from uninfected cells. (A-C) samples 
from three different donors and (D) composited graph from the three donors. PBMCs were 
infected with Mtb at MOI 0.001 and 100ul of cell culture supernatant was removed at day 0, 
1, 4, and 7, at the same time as photographs were taken.  An equal volume of complete 
medium was replaced.  MMP concentrations were analysed by Luminex array. Broken line 
uninfected, filled line Mtb-infected PBMCs. Mean concentration was analysed from 3 
experimental replicates per donor. Error bars = standard deviation.  
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8.2.3 Increased functional activity of MMP-9 in the IVG model 
MMP-1, -7 and -9 were upregulated in the Mtb infected PBMCs, and MMP-9 concentrations 
were highest in the IVG model. Therefore, gelatin zymography was performed to study the 
kinetics and functional activity of MMP-9 secreted from TB infected PBMCs (figure 23). 
Zymography is a semi-functional electrophoretic technique used to detect hydrolytic 
enzymes, based on their substrate repertoire (Vandooren et al., 2013). Each sample is 
electrophoresed on a gel containing gelatin, and after two washes to allow protein refolding, 
incubated overnight in proteinase buffer to allow degradation of gelatin.  On staining with 
bromophenol blue, areas of proteolytic activity appear as a clear band on a blue background.  
MMP-9 activity measured by gelatin zymography correlated closely with the immunoreactive 
protein detected by Luminex and showed increased gelatinolytic activity from day four in TB 
infected cells.  Consistent with MMP-9 secretion profile, there was also a late increase in 
MMP-9 secretion at day eleven in the control cells. 
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Figure 23: Increased enzymatic activity of MMP-9 in the IVG model. 
A gelatin zymogram showing bands of gelatin breakdown demonstrating the secretion 
kinetics of MMP-9 from the IVG model (top). Densitometric analysis of the zymogram bands 
using Scion image analysis (below). Gelatinase activity was analysed from 3 experimental 
replicates from one donor, and data shown are representative of results from 3 different 
donors. Error bars = standard deviation. Broken line uninfected, filled line Mtb-infected 
PBMCs. 
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8.2.4 DQ collagen degradation in the IVG 
I have shown that the functional activity of MMP-9 in the gelatin zymography was increased 
in the presence of the Mtb. I then wanted to study the functional effect of Mtb-induced 
collagenases on the collagen component of the ECM when added to the IVG model. 
Collagenase activity is relatively more difficult to demonstrate by casein zymography as it is 
a slower proteolytic process.  Therefore, I incubated freshly isolated PBMCs with DQ 
collagen and infected them with Mtb at MOI 0.001 and observed under confocal microscopy. 
DQ substrates have excessive fluorescent dyes attached so that the fluorescence signals are 
quenched. The intact collagen causes quenching of the signal because of the closer proximity 
of the fluorophores. The collagenase-driven hydrolysis of the collagen causes separation of 
the fluorophores molecules from one another and the fluorescence signal increases. At day 7, 
the Mtb-infected PBMCs wells showed increased collagen degradation around cellular 
aggregates (figure 24). 
 
8.2.1 Green collagen degradation in the IVG model 
This assay works the opposite way to the DQ collagen assay in the previous section. Here, I 
plated green fluorescent collagen in the wells and then freshly isolated PBMCs were added 
with or without Mtb infection. This collagen is FITC conjugate and green fluorescence 
signals can only be detected when the collagen is intact. Once collagen is destroyed, the 
fluorescent molecules will be detached and signal will be lost. I could detect clear green 
fluorescence in areas where the collagen is intact (figure 25). However, areas of cellular 
aggregates in Mtb-infected PBMCs showed marked loss of green signal, demonstrating the 
collagen degradation in these areas. 
123 
 
 
 
Figure 24: DQ collagen degradation in IVG model. 
Green fluorescence signals can be seen in areas of collagen destruction at cellular aggregates. 
A) Green fluorescence channel. B) Bright field channel. C) Merged of the two channels. 
Scale bars 25μm. Images are representative of 3 experimental replicates from one donor, and 
data shown are representative of results from 3 different donors. 
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Figure 25: Fluorescent collagen degradation in IVG model. 
Mtb-infected PBMCs associated with collagen destruction as demonstrated by loss of green 
collagen signal in the infected wells only. A) Green FITC channel. B) Bright field channel. 
C) Merged of the two channels. Scale bar 25μm. Images are representative of 3 experimental 
replicates from one donor, and data shown are representative of results from 2 different 
donors. 
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8.2.2 TIMP secretion by TB infected PBMCs 
Next, I analysed TIMP secretion from TB infected PBMCs by luminex array to determine 
whether the increased MMP secretion was compensated for by increased secretion of their 
inhibitors (figure 26). TIMP-1 concentration was found to be significantly higher in TB 
infected cells than the control ones, with a 5-fold increase in secretion at day 4. The secretion 
was increasing with time along with the increase in MMP-1, -7 and -9 in the previous 
experiment. TIMP-2 secretion from TB infected cells increased over time but was no 
different between the control and TB-infected cells. TIMP-3 and -4 were undetectable 
throughout the time course of the experiment, confirming that TIMP-1 and TIMP-2 are the 
dominant secreted inhibitors by PBMCs.  The concentration of TIMP-1 at day 7 was 46,000 
pg/ml while MMP-9 was 420,000 pg/ml (9 folds more) suggesting that there will be an 
excess of protease activity over the inhibitors as a result of the more pronounced MMP 
upregulation. 
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Figure 26: Secretion of TIMPs by in vitro granuloma model. 
A progressive increase in TIMP-1 concentration in TB infection of PBMCs compared to the 
control. TIMP-2 showed increase concentrations but in both control and infection. Broken 
line control, filled line Mtb-infected PBMCs. Mean concentration was analysed from 3 
experimental replicates per donor, and data shown are representative of results from 2 
different donors. Error bars = standard deviation. 
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8.2.3 RT-PCR analysis from TB-infected PBMCs 
Next, I determined whether increased MMP secretion resulted from increased gene 
transcription. In the previous experiment, MMP-1, -7 and -9 have been found to be secreted 
significantly more in Mtb infected PBMCs compared to uninfected cells. In order to measure 
MMP-1, -7 and -9 relative gene expressions, PBMCs were infected with Mtb at the similar 
experimental conditions and then RNA was harvested at 72 hours post infection.  
Mtb-infected PBMCs have shown a 41 fold increase in MMP-1 and a 65 fold increase in 
MMP-7 gene expression compared to control cells (figure 27). MMP-9 gene was upregulated 
by 8 fold increase in Mtb infected cells compared the control. The housekeeping gene was 
18S, which I found to be the most stablely expressed after studying 18S, beta Actin and 
GAPDH, Therefore, increased secretion is secondary to increased mRNA accumulation in 
cells. 
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Figure 27: MMP-1, -7 and -9 gene expressions are upregulated in Mtb infected PBMCs. 
PBMCs were infected at MOI 0.001 and then total mRNA extracted at day 4 by Trizol lysis 
and extraction on Invitrogen columns.  After synthesis of cDNA, relative mRNA levels of 
MMP-1, -7 and -9 were analysed by RT-PCR after normalisation to 18s as a housekeeping 
gene. Fold change was calculated from 3 experimental replicates per donor, and data shown 
are representative of results from 3 different donors. Error bars = standard deviation. 
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8.2.4 Effect on MMP and TIMP secretion from PBMCs infected with UV-
killed Mtb 
The initial experiments all used live Mtb. However, by using live mycobacteria, this not only 
limited me to performing all these studies in the containment level 3 suite, but also I noted 
progressive increase in the size of clumps of bacteria as the granuloma progressed due to 
ongoing Mtb growth. Consequently, it was important to determine whether the increasing 
size the granuloma related to increased mycobacterial growth or greater cellular recruitment. 
To investigate this question, I then performed studies using both live TB and UV-killed Mtb 
to determine whether UV-killed Mtb could be used to model the granuloma. IVG formation 
was seen in both live and killed Mtb with similar structures and kinetics (figure 28). 
MMP and TIMP secretion from PBMCs infected with UV-killed Mtb was studied to examine 
if there is any effect of UV-killing of the microbe on MMP secretion. The experiment was 
repeated with similar conditions using both live and dead Mtb.  UV-killed Mtb was made by 
exposing Mtb at mid log growth at OD 0.60, which corresponds to 1 x 10
8
 CFU per ml, for 
one hour and then re-checking the OD post UV killing and restoring the OD to 0.60 to 
account for evaporation. MMP-1, -7 and -9 concentrations increased in both live and dead TB 
infected wells compared to uninfected ones and that is consistent with the previous secretion 
experiment (figure 29).  
Consistent with the previous result, MMP-9 was also the most significant quantitatively 
secreted MMP in PBMCs infected with both live and UV-killed Mtb. MMP-1 and MMP-7 
were both significantly increased, and no difference was noted between the TB stimulated 
wells and the UV-killed Mtb stimulated wells. MMP-3 and -8 secreted from infected PBMCs 
with either live or dead bacilli showed no difference than that from control cells. Similarly, 
TIMP secretion experiment using UV-killed Mtb was consistent with experiments using live 
130 
 
Mtb. Both live and dead Mtb induced 2 fold increase in TIMP-1 secretion from PBMCs at 
day 6 and 12 compared to the uninfected control cells (figure 30). TIMP-2 concentration did 
not differ between the infected and uninfected cells, with an increasing level over the time 
course of the experiment. TIMP-3 and -4 were undetectable throughout the experiment. 
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Figure 28: UV-killed Mtb induces similar cellular aggregation of PBMCs to live Mtb. 
Inverted microscopy images of PBMCs stimulated with UV-killed Mtb observed under 
inverted microscopy at day 9. UV-TB induced similar cellular aggregates with similar 
kinetics to PBMCs infected with live Mtb (x20). Images are representative of five 
independent experiments. 
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Figure 29: UV-killed Mtb induces similar MMP secretion pattern to live Mtb.   
Mtb was killed by UV radiation and used to infect PBMCs and then supernatant harvested at 
different time points. MMP-1, -7 and -9 concentrations progressively increased in TB-
infected PBMCs in the first 9 days and the pattern was similar in both live and UV-killed Mtb 
infection. Mean concentration was analysed from 3 experimental replicates per donor, and 
data shown are representative of results from 3 different donors. Error bars = standard 
deviation. 
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Figure 30: TIMP-1 and -2 secretions from live and UV-killed Mtb showed similar 
pattern. 
PBMCs infected with UV-killed Mtb showed similar secretion pattern to live TB.  
Supernatants from the experiment described the previous figure were analysed for TIMP-1 
and -2 concentrations by ELISA. TIMP-1 was increased 2 folds at day 6 and day 12.  No 
significant difference in TIMP-2 secretion between control and stimulated cells was 
observed. Mean concentration was analysed from 3 experimental replicates per donor, and 
data shown are representative of results from 3 different donors. Error bars = standard 
deviation. 
  
134 
 
8.2.5 Viability of PBMCs after infection with Mtb 
To assess cell viability in the IVG model, I stained the Mtb-infected PBMCs with Annexin V 
and PI. Annexin V is a phospholipid-binding protein that has a high affinity for phosphatidyl 
serine (PS) which is translocated from the inner to the outer surface of the plasma membrane 
in apoptotic cells. PI binds to double stranded DNA by intercalating between basepairs. Since 
PI is membrane impermeant, it is excluded from viable cells with intact plasma membranes 
(Moore et al., 1998).  Therefore, cells which are positive for Annexin V are apoptotic, PI are 
dead and cells which stain for neither are live.  Both control and Mtb-infected PBMCs 
showed more than 80% survival after 7 days of infection (figure 31).  
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Figure 31: Control and Mtb-infected PBMCs showed more than 80% survival after 7 
days of infection. 
Control and TB-infected PBMCs were stained with Annexin V, a marker for apoptosis and 
PI, a marker for dead cells at day 7. PBMCs which are positive for Annexin V are apoptotic, 
PI are dead and cells with stain for neither are live.  Both control and Mtb-infected PBMCs 
showed more than 80% survival after 7 days of infection. Data are representative of 3 
experimental replicates per donor, and data shown are representative of results from 2 
different donors. 
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8.2.6 Effect of collagen on cell survival of Mtb-infected PBMCs 
In the previous experiment, I showed that both control and infected cells survived similarly 
for 7 days. Here, I wanted to investigate the role of collagen on cell viability in this model 
because my mouse studies in the MMP-1 expressing mice suggested that collagen destruction 
is likely to be an important initial step in pathology by reducing cellular survival. Collagen 
was added in different concentrations to Mtb-infected wells. Cell viability was assessed by 
measuring Lactose dehydrogenase (LDH) concentrations in the supernatants.  
LDH is found in cytosol of cells (Decker and Lohmann-Matthes, 1988). It is released into cell 
culture media in the event of plasma membrane damage. Therefore, LDH can be detected in 
tissue culture supernatants and used as biomarker for cellular cytotoxicity and cytolysis 
(Korzeniewski and Callewaert, 1983). Addition of collagen to the IVG model showed 
reduced release of LDH, indicating enhanced cells’ viability (figure 32). PBMCs survived 
better when adding collagen to the wells in a dose dependant manner as demonstrated by less 
LDH release from Mtb-infected PBMCs cultured with more collagen concentration.  
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Figure 32: Addition of collagen to Mtb-infected cells improves their survival. 
Mtb-infected PBMCs reveal enhanced cell survival when co-cultured with increasing 
collagen concentration when analysed by LDH assay. LDH is released in the supernatant by 
dead cells and used as a marker of cell death. PBMCs were infected at MOI 0.001 and cell 
culture supernatant was harvested after 72 hours and analysed for LDH concentration by 
ELISA.  Data are expressed as percentage of dead PBMCs in the wells. LDH toxicity was 
calculated 3 experimental replicates per donor, and data shown are representative of results 
from 3 different donors.  
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8.2.7 Cytokines 
Cytokines are critical mediators in the host immune protection against Mtb infection and are 
involved in regulating cellular recruitment, activating cells and up-regulating MMPs from 
various cell types. Conversely, MMP-9 is known to cleave several cytokines and chemokines 
(Opdenakker et al., 2001), and so a complex interplay may take place. Cytokines have not 
been investigated in an in vitro model of TB granuloma, with studies to date primarily 
focusing on mycobacterial determinants of pathogenicity (Puissegur et al., 2004, Puissegur et 
al., 2007). Therefore, I profiled the kinetics of cytokines, chemokines and growth factors 
released from granulomas into tissue culture supernatants from the IVG model by Luminex 
array. 
Cytokines, chemokines and growth factors measured in supernatants of granulomas induced 
by infection with either live or killed Mtb showed a similar pattern of increased 
concentrations compared to the uninfected wells. TNF-α and IL-1β peaked within 24 hours 
and then concentrations dropped gradually over time (figure 33). IFN-γ, however, showed 
similar pattern but with relatively delayed peak concentration at day 9 followed by decline in 
concentrations.  IL-12 concentration although peaked at day one, it stayed relatively at 
similar level throughout the time course of the experiment. Th2 cytokines showed notable 
lower concentration levels compared to Th1 cytokines (figure 34). IL-10 level peaked at day 
1 followed by a decrease in concentration until it was undetectable at the end of the 
experiment. IL-5 and IL-13 were of constant levels after peaking at day one. 
I have also profiled chemokines and found that Mtb-infected PBMCs secrete IL-8, IP-10, 
MIP-1α, MIP-1β, MCP-1 and MIG more than the control cells (figure 35). IP-10, MCP-1 and 
MIG concentrations progressively increased till peaking at day 9 but also showed more 
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upregulation in PBMCs infected with live Mtb compared to UV-killed Mtb (p value 0.04, 
0.03, 0.03 respectively). IL-8, MIP-1α and MIP-1β levels were upregulated by Mtb infection 
and peaked at day 1 then IL-8 remained at high levels while MIP-1α and MIP-1β 
concentrations dropped gradually until then became undetected.  
The growth factors GCSF, GM-CSF and VEGF concentrations in the supernatant of live and 
UV-killed Mtb-infected PBMCs were upregulated and peaked at day one and remained high 
(figure 36). However, live Mtb-infected PBMCs showed a 7-fold increase of GM-CSF 
compared to that upregulated by UV-killed Mtb. Other cytokines were found upregulated in 
different patterns and showed in (figure 37). Table 2 summarises the cytokines profiled and 
their upregulation status.   
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Figure 33: Th1 cytokines are upregulated in the IVG model. 
Th1 Cytokines measured in supernatants of granulomas induced by infection with either live 
or killed Mtb showed a similar pattern of increased concentrations compared to the 
uninfected cells. IL-1β and TNF-α levels peaked at 24 hours and then dropped gradually 
while IL-12 stayed at similar levels after peaking at 24 hours. IFN-γ showed increasing 
concentrations and peaked at day 9 before declining. Mean concentration was analysed from 
3 experimental replicates per donor, and data shown are representative of results from 2 
different donors. Error bars = standard deviation. 
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Figure 34: Th2 cytokine upregulation is relatively less in the IVG model. 
Concentrations of Th2 cytokines are notably less than Th1 cytokines. Maximum 
concentrations are 11.52 pg/ml for IL-5, 73.95 pg/ml for IL-10 and 14.99 pg/ml for IL-13, 
compared to 934.5 pg/ml for TNF-α and 697 pg/ml for IFN-γ. Mean concentration was 
analysed from 3 experimental replicates per donor, and data shown are representative of 
results from 2 different donors. Error bars = standard deviation.  
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Figure 35: Upregulation of chemokines in the IVG model. 
Mtb-infected PBMCs secrete IL-8, IP-10, MIP-1α, MIP-1β, MCP-1 and MIG more than the 
control cells. High chemokine concentrations were achieved relative to the cytokines, such as 
73,682 pg/ml MCP-1 and 72,419 pg/ml IL-8. Mean concentration was analysed from 3 
experimental replicates per donor, and data shown are representative of results from 2 
different donors. Error bars = standard deviation. 
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Figure 36: Mtb upregulates growth factors in the IVG model. 
 GCSF, GM-CSF and VEGF concentrations in the supernatant of Live and UV-killed Mtb-
infected PBMCs were upregulated and peaked at day one and remained high. After day 6, 
live Mtb appears to upregulate more GMCSF than UV-killed Mtb. Mean concentration was 
analysed from 3 experimental replicates per donor, and data shown are representative of 
results from 2 different donors. Error bars = standard deviation. 
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Figure 37: Other cytokines and receptor antagonists detected in the IVG model. 
Cytokines that do not fall into the classical TH1/2 division are shown.  IFN-α, which is 
usually associated with antiviral responses, is elevated by Mtb infection but to modest levels. 
IL-6 reaches very high concentrations, over 10,000pg/ml, whereas IL-7 concentrations, while 
elevated, were low. Mean concentration was analysed from 3 experimental replicates per 
donor, and data shown are representative of results from 2 different donors. Error bars = 
standard deviation. 
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IL-1β ↑↑ IL-17 ND 
IL-12 ↑↑ RANTES ↔ 
IFN-γ ↑↑ Eotaxin ND 
TNF-α ↑↑ IL-8 ↑↑ 
IL-2 ND  MIP1α  ↑↑ 
IL-2R ↑↑ MIP-1β ↑↑ 
IL-4 ND MCP-1 ↑↑ 
IL-5 ↑  IP-10 ↑↑ 
IL-10 ↑↑ MIG ↑↑ 
IL-13 ↔  G-CSF ↑↑ 
IFN-α ↑↑ GM-CSF ↑↑ 
IL-6 ↑↑ VEGF ↑↑ 
IL-7 ↑↑ FGF-Basic ↑  
IL-RA ↑↑ HGF ↔  
IL-15 ↔  EGF ND 
 
Table 2: Summary of 30 cytokines, chemokines and growth factors screened in the in 
vitro granuloma model. 
 ↑ upregulated, ↔ no change and ND nothing detected. Chemokines are highlighted in red 
and growth factors in blue.  
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8.3 Discussion 
 
I have adopted an IVG model of TB originally developed by Altare’s group (Puissegur et al., 
2004) and others (Seitzer and Gerdes, 2003, Birkness et al., 2007, Wang et al., 2013, Parasa 
et al., 2014) to investigate how MMPs and cytokines are upregulated and the effect on ECM 
destruction. I have infected freshly isolated PBMCs with low dose of Mtb and shown the 
progressive recruitment of immune cells such as monocytes/macrophages and T cells around 
the mycobacterial bacilli to form a granuloma structure.  MMPs profiled in the supernatant 
harvested from Mtb-infected PBMCs showed an increased secretion of MMP-1, -7, -8 and -9. 
MMP-9 was the most abundant amongst them and its functional activity demonstrated by 
gelatin zymography showed similar kinetics to its secretion profile. I observed some 
variations between donors as expected with work with primary human cells. However, in all 
cases, TB infection upregulated key MMPs. The variability in the maximal concentrations 
reached in infected cells. This variability results from both seeding density and donor-donor 
variability. In addition, BCG vaccination status of the donors is not known; therefore, this 
may affect the timing and the strength of the immune response against Mtb infection in the 
model. The key finding in every donor is that MMPs are upregulated in TB-infected cells 
showing the robustness of the result. 
 Then, I have demonstrated the functional activity of MMP-1 causing degradation of DQ and 
green fluorescent collagen. Collagen destruction was only seen in TB-infected PBMCs and 
that was not because of the difference in cell death. Also, adding collagen in increasing 
concentrations enhanced cell survival of Mtb-infected PBMCs. 
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RT-PCR for MMP-1, -7 and -9 shows that upregulated of secretion in Mtb-infected cells is 
due to an increased mRNA accumulation. TIMPs were also profiled and I found TIMP-1 
concentrations to be significantly increased in TB granuloma compared to the control wells 
but the relative concentrations compared to peak MMP concentrations was relatively lower. 
Cytokines, chemokines and growth factors were profiled and I found an upregulation of Th1 
and Th2 cytokines in addition to chemokines and growth factors. 
The IVG model was developed by Altare and other groups and they used it to primarily 
investigate virulence factors of Mtb and host-microbe interactions. However, MMPs and their 
activities have not previously been studied in this model. I have replicated this model using 
freshly isolated PBMCs and infected them with Mtb to study MMPs’ secretion and function. 
Also, I have started to develop the model by adding ECM components such as collagen to the 
wells and investigating how the cell-matrix interactions may affect cellular viability in this 
model. Although it was straightforward to measure secreted factors, one of the challenges I 
had was finding a way to measure cellular aggregates and quantify them as they are variable 
in sizes and numbers.  Although it would be possible to take serial photographs of an entire 
well and quantitate the number and area of granuloma formation, this would be time 
consuming, require large data files and be susceptible to bias by the analyser unless blinded. 
I showed that MMP-1, -7 and -9 were upregulated in TB infection in the IVG model. It has 
been demonstrated that MMP-1 and -3 were upregulated in induced sputum and BAL fluid of 
patients with active pulmonary TB (Elkington et al., 2011). Furthermore, multiple MMPs as 
well as TIMP-1 and -2 concentrations were elevated in induced sputum from TB patients and 
were correlated with disease severity (Ugarte-Gil et al., 2013). After receiving TB treatment, 
concentrations of MMP-1, -3 and -8 dropped sharply suggesting the resolution of matrix 
destruction phenotype (Ugarte-Gil et al., 2013). MMP-1 and -7 expression have been 
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demonstrated around TB granulomas in lung biopsies (Elkington et al., 2005b). Upregulation 
of MMP-9 was found in pleural effusion of TB patients compared to transudates and 
malignant pleural effusions of patients with lung cancer (Park et al., 2005). 
Immunohistological sections from patients with tuberculous lymphadenitis showed strong 
staining for MMP-9 at monocyte/macrophage infiltration surrounding areas of caseous 
necrosis (Price et al., 2003). CSF from patients with tuberculous meningitis revealed more 
MMP-9 concentrations than that in bacterial or viral meningitis, and that increase was 
associated with intracerebral tissue injury (Price et al., 2001).  Therefore, the MMPs that I 
found to upregulated in the model reflect MMPs that have been identified in man, such as 
MMP-1, -7 and -9.  However, I did not demonstrate MMP-3 upregulation, which has been 
shown to be increased in induced sputum in 3 separate studies (Elkington et al., 2011, Walker 
et al., 2012, Ugarte-Gil et al., 2013). MMP-3 was present in high quantities in human serum, 
which may have masked low level upregulation of MMP-3.  This illustrates the inherent 
challenges in replicating all events in vivo in a cell culture model, and that although we were 
able to replicate several of the features seen in man, considerable further modification and 
optimisation will be required before it can more fully be used to study events in man. 
Several MMPs have been implicated in the granuloma formation and TB pathogenesis. 
Human monocytic THP-1 cells and primary monocytes secreted more MMP-1 and -9 when 
infected with Mtb than when incubated with latex beads (Friedland et al., 2002). In a 
comprehensive profiling of MMPs, MMP-1, -3, -7 and -10 were upregulated in human 
macrophages infected with Mtb (Elkington et al., 2005b). In clinical and a cellular model of 
TB infection, MMP-1 was found upregulated after infection with Mtb but not the vaccine 
strain, BCG, which does not cause cavitation in the lung (Elkington et al., 2005b). In a 
zebrafish model of M. marinum, MMP-9 knockout embryos showed decreased monocyte 
recruitment to the granulomas formed that even were of less in numbers and smaller in size 
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(Volkman et al., 2010).  The suppressed cellular recruitment was found to be due to loss of 
ESAT-6 dependent upregulation of MMP-9 from epithelial cells, which then generated a 
migration gradient for monocytes.  However, the substrate of MMP-9 that leads to this 
gradient has not been identified.   
TIMPs bind to MMPs in a 1:1 manner to block access of substrates and inhibit their action. In 
addition, they play role in various functions, including promoting cell growth, matrix binding, 
inhibition of angiogenesis and the induction of apoptosis (Brew et al., 2000). TIMPs appear 
to act in pericellular environment to inactivate MMPs; for example, MMP-9 activity was 
found unopposed by TIMPs at granulomas in lymph nodes of patients with tuberculous 
lymphadenitis (Price et al., 2003).  Although TIMPs were upregulated by infection in the 
model, the relative ratio of TIMPs to MMPs was low, and so the overall effect on matrix 
turnover would be predicted to be proteolysis. 
I have shown that TNF-α, IFN-γ, IL-1β and IL-12 concentrations were increased in the IVG 
of TB more than that of Th2 cytokines. In TB patients, Th1 cytokines were produced at 
higher concentrations at the site of infection compared to Th2 cytokines (Vankayalapati et al., 
2003). TNF-α plays a significant role in activating monocytes/macrophages, acting in 
synergy with IFN-γ to induce antimicrobial activity (Mootoo et al., 2009). Interference with 
IFN-γ has rendered mice more susceptible to Mtb infection and patients with mutations of the 
IFN-γ/IL-12 signalling pathway are hypersusceptible to mycobacterial infection (Flynn et al., 
1993, Cooper et al., 1993). TNF-α, IFN-γ, IL-6 and IL-8 concentrations were also found to be 
elevated in Mtb-infected PBMCs and autologous macrophages (Birkness et al., 2007). 
Similarly, the developing granuloma was shown to be TNF-α dependant as demonstrated by a 
delayed onset of granuloma formation in TNF-deficient mice (Algood et al., 2005, Saunders 
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and Britton, 2007). Treatment of patients with anti-TNF medication increases their incidence 
of TB reactivation (Keane et al., 2001). Therefore, similar to my findings with MMPs, I was 
able to demonstrate similar cytokines are upregulated by infection in the granuloma model as 
in man, and potentially this model could be used to study the effect of interfering with 
specific cytokine or chemokine signalling with monoclonal antibodies on granuloma 
formation and the control of Mtb growth. 
MMPs can modulate ECM integrity and also cleave cytokines and chemokines to modulate 
their activities (McQuibban et al., 2000). For instance, MMP-2, -3 and -9 can activate IL-1β 
precursor, and MMP3 is also involved in degrading the active IL-1 β, playing dual role in 
modulating cytokine activity. MMP-2 and -9 can activate latent TGF-β and several MMPs 
play significant roles in activating recombinant soluble proTNF-α (Yu and Stamenkovic, 
2000). Furthermore, MMP-1, -13 and -14 were found to be playing a role in cleaving the N-
terminus of MCP-1, MCP-2 and MCP-4 to produce antagonist factors (McQuibban et al., 
2002). Therefore, there is a complex interaction between MMPs and key host 
immunomediators that require advanced cell culture models to dissect. I demonstrated that all 
these mediators were induced by TB infection, and therefore this system could be developed 
further to investigate this protease-cytokine cross-talk more fully. 
I have shown that Mtb-infected PBMCs survived better when they were cultured with 
collagen. It is widely believed that ECM components are not only physical scaffold structure, 
but they also modulate cellular behaviour (Streuli, 1999). Although collagen was recognised 
as cell survival factor in various studies, its role in TB field is not widely reported. Several 
examples of matrix acting as cell survival factors exist. For example, poor graft viability was 
limiting cardiac cell transplantation, however, adding collagen to H9c2 cardiomyoblasts not 
only improved its early survival but also lead to enhanced left ventricle function in a rat 
model (Kutschka et al., 2006). Expression of collagen type I and type IV around pancreatic 
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cancer cells showed inhibited apoptosis and enhanced growth and migration of these 
cancerous cells (Ohlund et al., 2013).  
Taken together, my data support the standard granuloma model as a novel system to 
investigate host-pathogen interactions in human and investigate key mediators released by 
host inflammatory cells. However, the primary limitation of this model is that it does not 
fully reflect the natural 3D interactions in the lung and the cell-matrix interactions that occur 
in a 3-D environment. Therefore, my next aim to take this model further was to develop a 3D 
granuloma model of TB. 
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9 DEVELOPING A 3D IVG MODEL OF TB TO STUDY HOST-
PATHOGEN INTERACTION 
 
9.1 Introduction 
 
 In my transgenic mouse experiments, I have shown that our humanised mice expressing 
MMP-1 developed human-like lung pathology. The MMP-1 expressing mice lung sections 
revealed pulmonary TB granulomas characterised by caseous necrosis in areas associated 
with ECM destruction supporting a critical role for MMP-1 as a final effector of this lung 
tissue pathology and also the role of ECM in regulating cell survival. Then, to dissect the 
early events in the granuloma formation and to confirm the role of MMPs in TB 
pathogenesis, I have replicated an IVG model. This model allowed me to monitor early 
events in the development of TB granulomas and also assess the potential role of ECM when 
incorporated with Mtb-infected PBMCs in this model. 
 
I have shown a progressive recruitment of immune cells overtime to form a granuloma-like 
structure in Mtb-infected wells. These granulomas were associated with upregulation and 
increased secretion of key MMPs, cytokines and chemokines. Moreover, Mtb-infected 
PBMCs were associated with collagen destruction and the proteolytic activity of the MMPs 
may drive this matrix breakdown. This model has provided insight into the formation of 
granulomas and revealed the role of ECM and its interaction with immune cells to provide 
better survival signals. However, although the standard cell culture system is widely 
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acceptable to provide invaluable information, I decided to take the IVG model further to 
develop a 3D model because cell-matrix interactions occur in 3 dimensions. 
Cellular behaviour is different when cells are cultured in a monolayer on plastic or glass 
surfaces compared to when impregnated in a 3D environment (Pampaloni et al., 2007). In the 
latter instance, cells will be in direct contact with matrix in all directions, reflecting 
conditions in the human body more accurately. Therefore, I have adapted a 3D in vitro 
granuloma (3D IVG) model of TB where freshly isolated PBMCs are impregnated in ECM 
components so that cell behaviour could be studied in an environment that is a better 
representation of in vivo conditions  more closely than standard cell culture. One of the 
limitations of the standard model was tendency of the formed granuloma structure to being 
disturbed when trying to change the medium or harvest supernatant. Therefore, another 
benefit of the 3D model is that it gives the advantage on keeping the granulomas structure 
intact within the matrix so that changing media and harvesting supernatants do not cause 
interruption to the wells. 
 
Also, I took part in experiments developing a novel model of an engineered in vitro 
granuloma (EVG) model of tuberculosis using a bioelectrosprayer system to encapsulate cells 
in microspheres. Freshly isolated PBMCs were suspended in alginate, which crosslinks in the 
present of divalent cations.  Droplets are extruded through a nozzle surrounded by an electric 
current to ensure consistent small bead formation, and fall into a crosslinking bath containing 
Calcium chloride (CaCl2) to generate small microsphere containing the cellular aggregates 
(Workman et al., 2014). The cells can be mixed with different ECM components and infected 
with Mtb to study the kinetic progression of cell aggregation as well as the role of ECM in 
regulating cell behaviour.  The model was initially developed by a post-doctoral researcher in 
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the laboratory, Liku Tezera, and I worked alongside him performing experiments analysing 
cell aggregation and MMP and cytokine secretion. 
 
9.2 Results of 3D IVG model 
9.2.1 Developing a 3D IVG model 
I have adapted a 3D tissue culture system developed by Cecilia O'Kane in the Hammersmith 
TB group that she used to study fibroblasts in 3-dimensional cell culture (O'Kane et al., 2008, 
O'Kane et al., 2010). I have performed initial experiments trying to optimize the model for 
direct infection of PBMCs by using different numbers of cells seeded and different 
concentrations of collagen and buffers. After separation, 1x10
6
 PBMCs were spun down to a 
pellet, resuspended in 2mls of collagen mixture and then 500μl seeded into two control wells 
on a Permanox 4-wells chamber slide. Mtb was added at an MOI of 0.001 to the remaining 
collagen suspension and this was seeded into the 2 TB wells. The collagen suspension mix 
composes of human type I collagen, 10% human AB serum, 10x RPMI, HEPES and 7.5% 
NaHCO3 to bring pH to neutral. I incubated the plate at 37
o
 C for one hour to allow gelation 
and then added 500μl complete RPMI on top of the gel.  The cells were incubated at 37o C 
and I monitored the progression of cellular aggregates’ development in TB-infected wells and 
harvested supernatants at different time points.  
When monitoring the cells in the slides at different time points, I noted that cells were able to 
migrate through the gel matrix. I also observed progressive cell aggregation over time in TB 
infected wells but not the control ones. The trend of cells aggregation looked similar to what I 
used to see in the standard IVG model where cell start to aggregate at day 3 and peaking at 
around days 7-9. By looking through the microscope and focusing up and down, it was 
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obvious that cells are able to move through the 3D gel. Because the cells are impregnated 
within a 3D structure, images acquired through a light microscope were unable to prove the 
three dimensional property of the formed structure. Therefore, I performed confocal 
microscopy of the 3D IVGs that had been fluorescently stained to study the 3-D structure. 
 
9.2.2 3D structure of the TB granulomas 
The 3D IVG model showed progressive recruitment of immune cells in the TB-infected wells 
observed under light microscopy. However, this was a rather subjective observation as the 
cells can be seen under the microscope that they are forming aggregates but was difficult to 
acquire images demonstrating this phenomenon due to the challenge of getting clear focus of 
aggregates in a 3-D gel. In order to obtain more reliable readout and observe the morphology 
of this model, I stained PBMCs with CellTracker™ green that stains cytoplasm in green 
fluorescence that can be detected under confocal microscopy. CellTracker™ green stains 
cytoplasm in live cells only; therefore, it also confirms viability of cells in the model. I 
observed progressive development of cellular aggregates within the TB-infected 3D collagen 
gel only (figure 38A). By day 7, it became evident that the formed granuloma-like aggregates 
was of a 3 dimensional structure property as demonstrated by multiple z-stack imaging 
(figure 38B).  
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Figure 38: Confocal images demonstrating 3D structure of the TB granulomas at day 7. 
Cellular aggregates of PBMCs infected with Mtb in 3D IVG model. A. confocal images of 
Mtb-infected PMBCs stained with CellTracker green that stains cytoplasm in live cells only, 
at day 7. B. Z-stack images at day 7 showing the 3D structure of the granuloma. Images are 
representative of 5 independent experiments.  
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9.2.3 MMP secretion from 3D IVG model 
After optimizing the 3D IVG model and observing that Mtb-infected PBMCs impregnated in 
the 3D collagen matrix showed a 3D granuloma-like structure, I studied the role of MMPs in 
this model. I profiled MMPs secreted in the supernatant of control and TB-infected wells at 
different time points (day 0, 1, 4, 7 and 11). MMP-1 concentrations in TB infected wells 
increased progressively and peaked at day 4 (12461pg/ml) and then dropped at days 7 and 11 
while control wells showed steady low levels of MMP-1 (figure 39). MMP-2 and -3 
concentrations were high from the beginning of the experiment and fell at day 4 but was no 
significant difference between control and TB wells. MMP-7 and -9 levels of the TB-infected 
cells were increasing and peaked at the end of the experiment (day 11) while the uninfected 
Mtb-infected PBMCs showed similar pattern but of lower concentrations. Control and TB 
wells showed also similar pattern of increasing concentrations of MMP-8, with TB-infected 
wells secreting more MMP-8 and both peaking at day 4 and then remaining at similar levels 
throughout the course of the experiment.  
However, although the results presented in figure 9 were relatively convincing, in subsequent 
experiments the results were variable from one experiment to another and I was unable to 
replicate similar secretion patterns in a robust and reproducible manner. MMP secretion did 
not differ between control and infected wells in approximately half of the experiments. I tried 
to identify any potential reason, such as variation in the cell culture medium, differences in 
cell isolation protocol, variable MOIs, but could not identify a cause.  I followed the same 
protocol utilising the same reagents and yet got divergent results.  One potential reason that 
might explain the difference in MMP secretion pattern in this model is that some MMPs 
might actually be trapped within the gel and not diffusing out to the supernatant, thereby 
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masking moderate levels of MMP upregulation. Therefore, I decided to test this hypothesis 
by measuring concentrations of MMPs within the gel made of different matrix components.  
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Figure 39: MMP secretion is increased in the 3D IVG model. 
Mtb-infected PBMCs were impregnated in collagen mixture and allowed to form a gel and 
then medium was added on top of the 3D gel. MMPs profiled in the 3D IVG model showed a 
kinetic pattern similar to the standard IVG model. I was unable to replicate similar secretion 
patterns in a robust and reproducible manner. Filled line, Mtb-infected, broken line, control 
cells. 
  
160 
 
9.2.4 MMP trapping in the 3D matrix gel 
Although the 3D IVG model showed progressive formation of cellular aggregates in Mtb-
infected wells, the MMP secretion pattern was inconsistent. One potential explanation was 
that MMPs may act at pericellular level and may not be able to diffuse out of the gel 
composed of ECM component, instead adhering to matrix fibrils within the gel. This may 
explain why MMPs are not being detected consistently in the supernatants harvested from the 
wells of 3D gel matrix. Therefore, I tested this hypothesis by measuring concentrations of 
MMPs within the 3D gel made from different matrices.  
Collagen, gelatin, agar and alginate were used separately to develop a 3D matrix gel and then 
the gels were disrupted by spinning at 14000rpm for 10 minutes and supernatant was 
harvested. MMPs were measured and compared to a standard that has a known concentration 
of each MMP. MMP-1, -2, -3, -7 and -8 showed no differences between the standard 
concentration and the MMP detected within the each matrix component (figure 41). 
Interestingly, concentration of MMP-9, a gelatinase, was very low in the collagen matrix gel, 
suggesting that MMP-9 does bind to collagen and this will reduce the amount that diffuses 
out of the gel into the surrounding medium.  
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Figure 40: MMPs trapped in matrix. 
Collagen, gelatin, agar and alginate were used separately to develop a 3D matrix gel and then 
the gels were disrupted by spinning at 14000 rpm for 10 minutes and supernatant was 
harvested. MMP-1, -2, -3, -7 and -8 showed no significant differences between the standard 
concentration and the MMP detected within the each matrix component. However, the 
concentration of MMP-9 was very low in the collagen matrix gel. Data are from 3 
experimental replicates per donor, and data shown are representative of results from 2 
different donors. Error bars = standard deviation. 
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9.2.5 Collagen/Agar experiment 
I have shown in the previous chapter that adding collagen to the standard granuloma model 
enhances cell survival in a dose dependant manner. Although I could not utilise the 3-D 
model to study MMP release, I wanted to investigate whether we could study matrix control 
of cell survival in 3 dimensions.  The first experiments were a variation on the 3-dimensional 
model in chamber slides, comparing agar gels with a collagen-agar gel.  In this 3D model, I 
wanted to examine the effect of impregnating PBMCs within a 3D collagen matrix on cell 
survival. Therefore, I compared growing the cells in gels made of collagen with gel made of 
agar as it would naturally gel and form a 3D structure but didn’t contain collagen. I harvested 
supernatants from wells of both collagen and agar 3D matrix gels and measured the 
concentration of LDH. 
 LDH is found in cytosol of cells and released into cell culture media in the event of plasma 
membrane damage (Decker and Lohmann-Matthes, 1988). Therefore, LDH can be detected 
in tissue culture supernatants and used as biomarker for cellular cytotoxicity and cytolysis 
(Korzeniewski and Callewaert, 1983).  PBMCs seeded within a collagen-based 3D gel matrix 
survived significantly better than those embedded in a 3D gel matrix composed of agar 
(figure 40). LDH release from dead cells in the agar matrix was double that of LDH detected 
in the supernatant of collagen matrix.  
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Figure 41: Cell survival in agar/collagen matrix gels. 
LDH assay shows that PBMCs impregnated in collagen matrix are associated with less cell 
toxicity compared to cells grown in agar matrix that form a gel but without collagen. PBMCs 
in contact with collagen survived better than those grown without collagen. LDH toxicity was 
analysed from 3 experimental replicates per donor, and data shown are representative of 
results from 2 different donors. Error bars = standard deviation. 
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9.3 Results of engineered IVG model 
9.3.1 Developing engineered in vitro granuloma (EVG) model 
The previous 3D IVG model showed that Mtb-infected PBMCs impregnated within the 
collagen matrix formed cellular aggregates of 3D structure inside the gel and survived better 
than when seeded in an agar gel matrix containing collagen as opposed to without collagen. 
However, despite the fact that the model worked partially, it was challenging to accurately 
define the role of MMPs in this model. The main obstacle was translating the interaction 
between cells and matrix within the gel into reliable readouts that can help in understanding 
the potential roles of MMPs.  
Therefore, I worked on a novel engineered in vitro granuloma (EVG) model of TB. This 
work was performed alongside with Liku Tezera and in collaboration with Suwan 
Jayasinghe. Liku is a postdoc who worked with our group in Hammersmith before leaving to 
Southampton to work with Paul Elkington. Suwan Jayasinghe leads the Bio-Physics Group at 
UCL who pioneered the ability to electrospray and electrospin living cells and whole 
organisms (Odenwalder et al., 2007, Poncelet et al., 2012). 
In this bioengineered model, PBMCs are suspended in a matrix containing alginate, with or 
without collagen and / or Mtb.  The matrix is injected through a nozzle surrounded by an 
electric field into gelating bath containing CaCl2 where the cells are encapsulated within 
microspheres by the cross-linking of alginate. Freshly isolated PBMCs can be mixed with 
different matrix components so that the encapsulation step keeps cells and matrix in direct 
contact. After washing the microspheres, I suspended them in complete RPMI and incubated 
the plate at 37
o
 C and harvested supernatant and acquired images at different time points. 
After performing initial optimising trials, microspheres containing Mtb-infected PBMCs were 
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being generated successfully and remained intact during the whole time course of the 
experiments, up to 21 days (figure 42).  
 
 
 
 
 
 
Figure 42: Light microscopy images of microspheres. 
Light microscopy imaging of Mtb-infected PBMCs encapsulated in microspheres by 
bioelectrosprayer. Images are representative of 4 independent experiments. 
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9.3.2 Confocal images of microspheres 
To gain more information about the developing structure inside the microspheres, we stained 
PBMCs for confocal studies. First, PBMCs were stained with DAPI, a fluorescent stain that 
binds to the DNA of the cells by passing through cell membrane (figure 43A). The 
fluorescence can only be seen inside the spheroids demonstrating the containment of PBMCs 
inside them. Also, we stained the PBMCs with Calcein AM, a cell permeant dye that can be 
used to determine cell viability. It is non-fluorescent that converts to a green-fluorescent 
Calcein, after acetoxymethyl ester hydrolysis by intracellular esterases in live cells (Gatti et 
al., 1998).  
By looking through confocal microscope, the green fluorescent signals demonstrate cell 
aggregates in the Mtb-infected microspheres. To confirm the 3D nature of the structure 
formed, multiple z stack images have been performed so that it can be packed together to 
allow the appreciation of the 3D property of the cell aggregates (figure 43B). 
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Figure 43: Confocal images of the EVG spheroids demonstrate cellular aggregation. 
Confocal images of cellular aggregates in the Mtb-infected PBMCs. A. PBMCs stained with 
DAPI that binds to the DNA of the cells. B. PBMCs with Calcein AM, a cell permeant dye 
that determine cell viability. The fluorescence can only be seen inside the spheroids 
demonstrating the containment of PBMCs inside them. Images are representative of 3 
independent experiments. 
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9.3.3 MMP secretion in the EVG model 
Now that I have demonstrated that cell encapsulation using our bioelectrosprayer model is 
revealing cell aggregation inside the microspheres, I wanted next to investigate upregulation 
of MMPs in the bioelectrosprayer model. I profiled MMPs secreted in the supernatant of the 
microspheres throughout the time course of the experiment (figure 44). Concentrations of 
MMP-1, -7, -8 and -9 in the supernatants of microspheres containing Mtb-infected PBMCs 
were higher than the uninfected ones. MMP-1 and -8 peaked at day 1 (2531pg/ml and 
14347pg/ml, respectively) of the experiment and remained at relatively stable levels. MMP-9 
concentration was the most abundant enzyme and peaked at day 5 when the level stayed at a 
plateaued. MMP-7 concentration was increasing progressively in the Mtb-infected spheres 
until the end of the experiment.  
MMP-2 concentration was initially high (3968pg/ml) and thought to be due to the MMP-2 
already present in the human serum, as MMP-2 concentration was high at day 0.  Similarly, 
initial MMP-3 concentration was high due to MMP-3 present in human serum, but no 
significant increased secretion occurred over time. MMP-2 and -3 concentrations showed no 
significant difference in control microspheres compared to the TB-infected spheres. 
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Figure 44: MMP secretion in the bioelectrospray model. 
Mtb-stimulated microspheres containing PBMCs secrete more MMP-1, -7, -8, -9 and -10 
than uninfected microspheres. Filled line, Mtb-infected, broken line, control cells. Mean 
concentration was analysed from 3 experimental replicates per donor, and data shown are 
representative of results from 3 different donors. Error bars = standard deviation. 
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9.3.4 Cytokines secretion in the EVG model 
Cytokines play important roles in TB immune response and involved in regulating cellular 
recruitment, activating cells and up-regulating MMPs from various cell types. I have shown 
the increased secretion of Mtb-infected PBMCs in the standard IVG model. Therefore, I 
profiled the kinetics of cytokines, chemokines and growth factors release from granulomas-
containing microspheres into tissue culture supernatants from the EVG model by Luminex 
array. 
IL-1β and IL-12 concentrations were higher in the Mtb-infected microspheres compared to 
the control ones and both cytokines increased over time and peaked at day 7 (figure 45). IL-
1β concentration then was dropping gradually while IL-12 remained at similar levels. Th2 
cytokines, on the other hand, showed notable lower concentration levels compared to Th1 
cytokines. IL-5, IL-10 and IL-13 were higher in the TB-infected PBMCs within the spheroids 
than in the control. IL-5, IL-10 and IL-13 levels were increasing progressively and peaked at 
day 7 followed by a slight decline in concentrations.  
I have also profiled chemokines and found that Mtb-infected PBMCs within the microspheres 
secrete IL-8, MIP-1α, MIP-1β and MCP-1 more than the control cells and peaked at an early 
time point (fig. 46). IL-8 stayed at similar level throughout the time course of the experiment. 
On the other hand, MCP-1, MIP-1α and MIP-1β concentrations decreased over time after the 
initial peak early on the experiment.  
Growth factors were also upregulated in the Mtb-infected PBMCs in the EVG model (figure 
47). VEGF and G-CSF concentrations were increasing from day 1 and reaching maximum 
levels at day 7 followed by a relative decline towards the end of the experiment. FGF-Basic 
was showing similar pattern to VEGF and G-CSF but peaked earlier at day 3. HGF 
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concentrations were steadily elevated during the time course of the experiment. Table 3 
summarises the cytokines, chemokines and growth factors profiled and their upregulation. 
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Figure 45: Cytokine secretion in the EVG model. 
Th1 and Th2 cytokines were profiled in the EVG model of TB. Mtb upregulated Th1 
cytokines (IL-1β and IL-12) and peaked early during infection experiment. Th2 cytokines IL-
5, IL-10 and IL-13 were also upregulated by Mtb but with concentrations less than the Th1 
cytokines except for IL-6 which reached 21,468 pg/ml at day 7. Filled line, Mtb-infected, 
broken line, control cells. Mean concentration was analysed from 3 experimental replicates 
per donor, and data shown are representative of results from 2 different donors. Error bars = 
standard deviation. 
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Figure 46: Chemokine secretion in the EVG model. 
Supernatants from encapsulated Mtb-infected PBMCs showed upregulation of IL-8, MCP1, 
MIP-1α and MIP-1β. Concentrations peaked at day 3 of the experiment followed by a decline 
in chemokines except for IL-8 that stayed at high levels throughout the experiment. Filled 
line, Mtb-infected, broken line, control cells. Mean concentration was analysed from 3 
experimental replicates per donor, and data shown are representative of results from 2 
different donors. Error bars = standard deviation. 
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Figure 47: Growth factors secretion in the EVG model. 
Although Mtb upregulated growth factors in the microspheres containing Mtb-infected 
PBMCs, concentrations were less than the cytokines detected. Filled line, Mtb-infected, 
broken line, control cells. Mean concentration was analysed from 3 experimental replicates 
per donor, and data shown are representative of results from 2 different donors. Error bars = 
standard deviation. 
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IL-1β ↑↑ IL-17 ND 
IL-12 ↑↑ RANTES ND 
IFN-γ ND Eotaxin ND 
TNF-α ND IL-8 ↑↑↑ 
IL-2 ND  MIP1α  ↑↑ 
IL-2R ND MIP-1β ↑↑ 
IL-4 ND MCP-1 ↑↑ 
IL-5 ↑  IP-10 ↑ 
IL-10 +/- ↑ MIG ND 
IL-13 +/- ↑ G-CSF ↑ 
IFN-α ND GM-CSF ND 
IL-6 ↑↑ VEGF ↑ 
IL-7 ↑↑ FGF-Basic +/- ↑ 
IL-RA ↑↑ HGF +/- ↑ 
IL-15 ↔  EGF ND 
 
Table 3: Summary of cytokine, chemokine and growth factor profiles in the EVG 
model. 
↑ upregulated, ↔ no change, +/- minimal upregulation and ND nothing detected. 
Chemokines are highlighted in red and growth factors in blue. 
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9.3.5 Cytokine secretion in the EVG model – effect of collagen 
Next I wanted to investigate the potential consequence of adding collagen to the PBMCs 
before getting them encapsulated on cytokine secretion profiled in the previous section to 
investigate the hypothesis that cell-matrix interactions may modulate the host immune 
response to Mtb. Therefore, I performed the same previous experiment to compare cytokine 
secretion pattern when PBMCs were with and without direct contact with collagen. So, I 
prepared 4 tubes containing PBMCs only, Mtb-infected cells, cells with collagen and Mtb-
infected cells with collagen and electrosprayed them separately. Overall, addition of collagen 
to the spheres leads to less cytokines detected in the supernatant except for MCP-1 that 
showed no significant difference with collagen addition (figure 48). IL-1β showed much less 
concentrations with the presence of collagen but with similar secretion pattern. 
 
9.3.6 Effect of collagen on cellular survival within microspheres 
In the standard IVG model, I showed that adding collagen to the cells enhances their survival. 
I wanted to examine the role of collagen in the EVG model to determine whether the findings 
in the agar model were consistent in the alginate microsphere system. Therefore, I made 
PBMCs suspensions in alginate either without or containing collagen and stimulated with 
Mtb. Each suspension was them sequentially bioelectrosprayed to generate microspheres 
containing PBMCs either with or without collagen. Supernatant was harvested from the 
spheroids and cell survival was assessed by LDH assay (figure 49). PBMCs that were mixed 
with collagen survived better than PBMCs with alginate only. 
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Figure 48: Collagen addition to the microspheres resulted in less cytokines detected in 
the EVG model. 
Mtb-infected PBMCs encapsulated using the bioelectrosprayer showed less Th1 cytokines 
(IL-1β and IL-12), Th2 cytokines (IL-5 and IL-6) and chemokine (IL-8). However, MCP1 
showed minimal decrease in concentrations after adding collagen to the cells. Mean 
concentration was analysed from 3 experimental replicates per donor, and data shown are 
representative of results from 2 different donors. Error bars = standard deviation. 
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Figure 49: Mtb-infected cells survived better when grown in the presence of collagen in 
the EVG model. 
Mtb-infected PBMCs were mixed with type I collagen and encapsulated in microspheres and 
incubated. Supernatant of these spheres were harvested and the LDH assay was performed to 
assess cell survival. PBMCs in contact with collagen showed less LDH toxicity than cells 
without collagen. Data are representative of 3 experimental replicates per donor, and data 
shown are representative of results from 2 different donors. Error bars = standard deviation.  
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9.4 Discussion 
 
I have adapted a 3D cell culture model to further develop the classical monolayer IVG model 
of TB. I have impregnated freshly isolated PBMCs in collagen gel matrix and observed the 
progression recruitment of the cells in the TB-infected wells that formed a 3D structure. The 
cellular aggregates formed in response to Mtb infection and were absent in the uninfected 
wells. The kinetic pattern of cellular recruitment to the developing lesion in this model was 
similar to what was observed in the previous standard IVG model. By day 3, Mtb-infected 
cells start to form small aggregates which then developed more obviously by day 7.  
The granuloma-like structure was confirmed by staining cells with CellTracker green that 
diffuse into live cells and stain cytoplasm in green. Combining images acquired by z-stack 
technique revealed that the formed aggregates in the Mtb-infected wells were detected at 
different levels demonstrating their 3D property. I harvested supernatants from wells of both 
collagen and agar 3D matrix gels and measured the concentration of LDH to assess cell 
viability. PBMCs grown within a 3D collagen gel matrix survived better than those 
impregnated in a 3D gel matrix composed of agar. When profiling MMPs in the supernatants 
of the 3D IVG model, I found TB infection leads to upregulation of MMP-1, 7, -8 and -9. 
However, I was not able to replicate similar results when repeating the experiment multiple 
times.  
In this chapter, I tried taking my cell culture studies further to resemble the environment in 
humans more closely. The previous standard culture system showed insight into the early 
events in TB granuloma formation. However, enhancing the granuloma model by 
impregnated cells within a matrix gel would allow for more understanding of the cell-matrix 
interaction and minimise the difference between cell culture and the normal physiological 
conditions of the lung tissue (Pampaloni et al., 2007). Furthermore, the formation of a 3D gel 
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matrix would provide a suitable environment for the MMPs to function locally on different 
matrices.  
Other researchers have also developed 3D IVG model and found results consistent with the 
results I observed. For example, Kapoor et al. reported an IVG of TB showing the 
development of Mtb dormancy in the granuloma which can be then resuscitated by immune 
suppression (Kapoor et al., 2013). They showed that human leukocytes formed granuloma-
like aggregates at day 8 after infection with Mtb, though granulomas were smaller than what I 
observed in my model. These granulomas found to be secreting cytokines like IFN-γ, TNF-α 
and IP-10 reproducing the in vivo scenario. 
Although the 3D cell culture model is favourable, it is associated with some technical and 
biological challenges. Dissolving the 3D matrix to isolate the cells or to study the local 
environment was one of the issues I was trying to address. Collagenase was used by other 
investigators to dissolve the collagen matrix but in my situation was not appropriate. This is 
because adding collagenase would lead to false results regarding concentrations of MMPs 
that I wanted to measure in this model. One of the possibilities of being unable to develop a 
reproducible 3D IVG model was that MMPs adhere to the matrix components and not diffuse 
into the supernatant efficiently. Therefore, I designed a matrix trapping experiment to identify 
any effect of matrix component that trap MMPs within it. MMPs appeared not to be trapped 
within the 3D gel except for MMP-9 that thought to be held within the collagen matrix. 
The results of this 3D IVG model of TB confirm the findings I showed in the standard IVG 
model. The kinetics of the leukocytes recruitment and progressive accumulation into a 
granuloma-like structure was similar in both models. Furthermore, the 3D model also 
confirms the survival signal provided by the cell-matrix interaction and that collagen is 
important in enhancing cell survival. However, the MMP secretion profile in the 3D IVG 
model could not be relied on as it was not reproducible when repeating the experiment. 
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Therefore, I was chose not to try to further develop this model to further study the cytokine 
profile and the role of MMPs in this model and moved to the bioelectrosprayer model instead. 
Then, I moved to a novel engineered TB model of IVG where cells are encapsulated and 
sprayed to generate microspheres. Different type of cells can be studied and different 
matrices can also be added to the cells using a bioelectrosprayer, though there was the 
inherent risk of working with, an as yet, unproven model. Here, I have infected PBMCs with 
Mtb and the formed microspheres were monitored for 14 days and supernatants were 
harvested and images were acquired. By day 4, cell aggregates were observed in the 
spheroids containing Mtb-infected PBMCs but not the uninfected ones. This is similar to 
what I used to see in my previous standard and 3D IVG models. The confocal imaging of 
these spheroids confirmed the survival of the PBMCs as well as the 3D property of the 
cellular aggregates in the infected wells. These models also confirm the importance of 
collagen as cell survival enhancer as PBMCs mixed with collagen survived better than those 
without collagen. 
The MMPs secretion profile showed that Mtb infection upregulated MMP-1, -7, -8 and -9. 
This is also consistent to the secretion profile of MMPs in the standard IVG model where I 
found upregulation of MMP-1, -7 and -9. When profiling the cytokines in this EVG model, 
Th1 cytokines, IL-1β and IL-12 were upregulated in the Mtb-infected PBMCs which is 
consistent with the standard IVG results. Th2 cytokines, IL-4, IL-5 and IL-10 were found to 
be low in concentrations though increased in TB infected microspheres more the uninfected. 
Chemokines and growth factors were also upregulated in TB. These findings are consistent 
with my previous in vitro models of TB and also with others published work (Kapoor et al., 
2013). Therefore, the EVG model of TB is able to recapitulate the in vivo findings in relation 
to cytokine and chemokine secretion by immune cells in response to Mtb infection.  
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In summary, I have taken the standard IVG model further and replicated a 3D model that 
showed that cell-matrix interaction is important in cell survival. However, due to some 
obstacles the role of MMPs in this model could not be revealed. The EVG model is a novel 
approach and may help provide valuable insight into TB pathogenesis. I have demonstrated 
the granuloma-like structure within microspheres and that adding collagen to the cells 
improves their survival. 
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10 CONCLUSION AND DISCUSSION 
 
I have shown that granulomas in lungs of patients with pulmonary TB showed the 
characteristic caseous necrosis and this was associated with ECM degradation. Then, I have 
studied the integrity of ECM in a humanised mouse model to investigate the potential role of 
MMP-driven matrix destruction in TB granulomas. Mice expressing human MMP-1 showed 
human-like lung pathology after being infected with Indo-Oceanic virulent strain of TB. This 
involves development of caseous necrosis in the lung granulomas and concurrent ECM 
degradation in these areas. The only difference between control and MMP-1 mice is the 
expression of human MMP-1, suggesting that these observations result from MMP-1-
mediated collagen destruction as these lesions are not seen in wild type or MMP-9 expressing 
mice infected with Mtb. However, the early stages of infection and the progressive formation 
of granuloma structure with the initial cell-cell interactions cannot be monitored in this model 
without extensive animal modelling. 
To investigate the underlying mechanism using an advanced cell culture model, I have 
replicated an IVG model of TB by infecting freshly isolated PBMCs with low dose of Mtb 
and shown the progressive recruitment of immune cells around the mycobacterial bacilli to 
form a granuloma structure. I have shown that Mtb causes upregulation of gene expression 
and secretion of MMP-1, -7, -8 and -9 in this model. Collagen degradation assays and gelatin 
zymography revealed the functional activity of MMP-1 and MMP-9, respectively. 
Furthermore, adding collagen in increasing concentrations enhanced cell survival of Mtb-
infected PBMCs, consistent with our hypothesis that the ECM regulates the host-pathogen 
interaction. Cytokines, chemokines and growth factors were profiled in this model and shown 
to be upregulated by Mtb. 
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To develop this model further to dissect the relationship between ECM and cellular responses 
to Mtb, I have adopted a 3D IVG model of TB so that it reflects the natural 3D interactions in 
the lung and the cell-matrix interactions that occur in a 3-D environment. I have impregnated 
PBMCs in collagen matrix gel and infected them with Mtb and observed that cells are able to 
move through the 3D gel and form 3D cellular aggregated with similar kinetic pattern to the 
previous standard IVG model. PBMCs cultured within a 3D collagen gel matrix survived 
better than those impregnated in a 3D gel matrix composed of agar only. The supernatants of 
the 3D IVG model showed that TB infection upregulated MMP-1, 7, -8 and -9. However, I 
was not able to replicate similar results when repeating the experiment multiple times and I 
found the model difficult to replicate consistently.  
Then, I moved to a novel EVG where cells are encapsulated and bioelectrosprayed to form 
microspheres. Consistent with findings in the standard and 3D models, the EVG model also 
showed the progressive recruitment of immune cells in the TB infected spheres to form a 
granuloma-like structure. MMPs, cytokines, chemokines and growth factor were also found 
upregulated by Mtb infection. I have also shown the enhanced survival of PBMCs when 
collagen is impregnated into the microspheres.  
The humanised-mouse model suggested that the ECM was playing an important but perhaps 
overlooked role in regulating host immune response in TB, since caseous necrosis was seen 
only in areas where cells lost their contact with lung ECM. This was driven by the 
collagenase MMP-1 as the WT and MMP-9 mice did not show a similar phenomenon. This 
conclusion was confirmed by cell culture models where Mtb-infected PBMCs in contact with 
collagen shown enhanced survival. This was the same in three different cell culture models, 
ranging from a relatively simple monolayer to three dimensional and bioelectrosprayer IVG 
models. 
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These data suggest a potential novel paradigm of TB pathology that the key sequence of 
events in TB pathogenesis start by phagocytosis of Mtb by macrophages that leads to 
upregulation of MMP-1 which cleaves lung ECM. As a result, the cellular survival signal 
from cell-matrix interaction is lost causing cell death and caseous necrosis (figure 50). This 
novel paradigm is directly opposite to currently proposed models (Dye and Williams, 2010, 
Russell et al., 2010), where the initial event is proposed to be cell death and this leads to 
collagen destruction.  This event resulting from of MMP-1 driven matrix destruction tend to 
be overlooked in the literature of TB pathogenesis. 
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Figure 50: A novel paradigm of TB immunopathology. 
A. the current widely held model of TB pathology proposes that cell death leads to caseous 
necrosis, which then causes lung ECM destruction, thereby resulting in pulmonary cavitation 
and transmission. B. my data demonstrate that the initial pathological event is proteolytic 
degradation of lung ECM, which then leads to both caseous necrosis and cavitation. 
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Matrix regulation of the host immune response to TB has widespread implications, but the 
role of the matrix in TB is not currently considered (Cooper, 2009, Ramakrishnan, 2012, 
O'Garra et al., 2013). Reviews of TB pathogenesis essentially overlook the role of the ECM 
in regulating interactions, but several other lines of investigation suggest that this may be an 
important omission. 
For example,  Newman et al. showed that human monocytes cultured in contact with collagen 
type I  were associated with significantly enhanced phagolysosomal fusion compared to cells 
grown on plastic (Newman et al., 1997), and phagolysosome fusion is a critical event in 
monocyte killing of Mtb. ECM has been shown to play a role in shifting the cytokine profile 
towards pro-inflammatory pattern in cancer (Merline et al., 2011), and so matrix integrity 
may skew the immune response. Chronic inflammation resulting in aberrant ECM expression 
and degraded matrix component have an impact on immune cell activation and survival and 
therefore regulates immune responses (Sorokin, 2010). 
Similarly, cell-matrix interactions regulate cell survival as shown in mammary epithelial cells 
that were detached from ECM and therefore glucose uptake was defective resulting in 
inhibited ATP generation and increased ROS levels (Buchheit et al., 2012). Furthermore, 
ECM is vital for epithelial cells growth and survival as cells detached from ECM have been 
shown to undergo autophagy (Lock and Debnath, 2008). Cell survival is thought to be central 
to the host-pathogen interaction in TB (Behar et al., 2010). However, the in vitro experiments 
dissecting these pathways have almost entirely been performed in the absence of ECM, and 
therefore conclusions drawn from these systems that do not contain ECM may not be a true 
reflection of events in the human lung, where initially all cells are adherent to ECM. Novel 
vaccination strategies need to consider the effects on matrix turnover, so that vaccination 
does not increase matrix destruction and thereby inadvertently worsen TB pathology.    
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Cell-matrix interactions affect multiple key processes in the immune response to TB. We 
demonstrated impaired bacterial control in cell culture (data not shown) but not in the MMP-
1 expressing mice, suggesting that longer murine experiments may be required because 
collagen breakdown is a very prolonged process (Lemaitre et al., 2001). One result is 
inconsistent with my hypothesis that the ECM is playing a key role in regulating the host-
pathogen interaction.  In cell culture, bacterial growth was restrained by cells adherent to 
collagen, but in the MMP-1 mice the colony counts were no different. This may result from 
the very slow kinetics of MMP-1 degradation in vivo.  For example, to develop aneurysms in 
MMP-1 mice crossed on the ApoE background, 18 months was required.  Therefore, we may 
need to perform more prolonged mouse infection experiments to determine whether increased 
bacterial loads are observed. 
 
I conclude that preserving matrix integrity improves the outcome of the host-pathogen 
interaction in TB and therefore targeting MMP-1 may improve the immunological control of 
TB. Doxycycline is approved by Food and Drug Administration (FDA) as a MMP inhibitor 
in periodontal disease where it was shown to reduce host-derived collagenase activity in 
gingival tissue of patients with periodontitis (Golub et al., 1997). Also, Ro32-3555 is a 
specific collagenase inhibitor that has undergone phase III clinical trials in Rheumatoid 
Arthritis (RA) and shown to be potential therapy for treating chronic degradation of 
articulating cartilage in RA and OA patients (Lewis et al., 1997).  Therefore, these orally 
available compounds could be repurposed to treat TB, preventing collagen breakdown and 
therefore not only reducing lung tissue damage but also improving host control of bacterial 
growth. 
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A central role for matrix breakdown in TB pathology is supported by unbiased approaches, 
but generally the implications have not been discussed by the authors of those studies.  For 
example, an investigation comparing the macrophage gene expression profile from patients 
with pulmonary TB to latently infected individuals identified MMP-1 as the most divergently 
regulated gene (Thuong et al., 2008), suggesting that excessive matrix destruction 
predisposes to developing TB.  Similarly, MMP-1 is one of the most highly up-regulated 
genes in infected human lung tissue (Kim et al., 2010).  A recent unbiased approach using 
aptamer technology identified protease-anti-protease balance and tissue remodelling as two 
key pathways that change during TB treatment, whereas cytokine pathways were not highly 
represented (De Groote et al., 2013).    
All TB treatments in the pre-antibiotic era, such as artificial pneumothorax, plombage and 
thoracoplasty, centred on macroscopic stabilisation of the ECM through cavity collapse, and 
these had a cure rate of up to 70% (Sellors, 1947, Dubos and Dubos, 1987). Tissue damage is 
emerging as a central determinant of the outcome of the host-pathogen interaction in other 
lung infections, such as bacterial-viral co-infection (Jamieson et al., 2013). They showed that 
tissue damage was the principle factor driving morbidity and mortality and that tissue repair 
rescued co-infected mice independently from microbial burden. This supports the hypothesis 
that preserving matrix integrity is fundamental to an effective response to infection.  
Altogether, my data demonstrate that destruction of the lung ECM is a critical initial event in 
the pathogenesis of TB. Matrix stabilisation strategies in TB may not only reduce morbidity 
and mortality, but may also help restore an efficacious immune response. 
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11 FUTURE WORK 
 
Concluding from my PhD, I believe that cell-matrix interactions need to be considered at the 
centre of TB pathophysiology. This can be developed in at least two separate lines of 
investigation; the mouse and cell culture models of TB.  
 
11.1 Mouse model 
 
The mice that I have used express MMP-1 in activated macrophages under control of the 
scavenger receptor A promotor/enhancer.  This has shown promising results but it would be 
interesting if we can express human MMP-1 in the epithelium as well. Stromal source of 
MMPs plays important roles in the in vitro cell culture models of TB (Elkington et al., 2005a, 
O'Kane et al., 2008).  Therefore, to increase the total MMP-1 expression, we could cross the 
macrophage MMP-1 expressing mice with mice that express human MMP-1 in the 
epithelium (D'Armiento et al., 1992). A second approach to increase the total proteolytic 
potential would be to cross the MMP-1 expressing mice with TIMP-1 knockout mice. In this 
model, the relatively un-opposed effect of pericellular MMP-1 activity would provide clearer 
role of the collagenase in the local tissue environment and more marked pathology may 
become evident at an earlier time point. Furthermore, humanised mouse models of TB can be 
used for MMP-1 inhibition studies to investigate TB pathogenesis as well as examining 
potential effects of the chemical compounds such as Doxycycline and Ro 32-3555 on TB-
infected mice to reduce immunopathology. 
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Different mycobacterial strains may also be compared in the transgenic mouse model to 
determine potential specific effect of certain strain. Mtb, M. bovis and Mycobacterium 
microti (the vole bacillus) are potential strains that can be used in TB infection experiments.  
Each mycobacterium has a specific predilection for each host, with Mtb being an obligate 
pathogen of man, and it may be that the mycobacteria that have evolved to cause disease in 
animals that are genetically closer to mice may cause pathology more rapidly. Mtb can be 
compared with M. bovis (from which BCG is prepared) as well as Vole bacillus that cause 
disease in voles, wood mice and other small mammals.  
 
11.2 Cell culture 
 
The standard IVG model of TB showed the upregulation of MMPs in TB and then the 3D 
IVG demonstrated the functional activity of MMPs in degrading ECM and therefore leading 
to cell death. I believe we can develop this model further and examine the effect of different 
matrices in the 3D environment. The model can be developed in diverse ways, for example 
by incorporating different matrices or different cell types.  For example, I could incorporate 
more cell types such as fibroblasts. Fibroblasts have been shown to be an important 
contributor to granuloma formation in human pulmonary TB (O'Kane C et al., 2007), and 
therefore incorporation may help more human-like granulomas to develop. Fibroblasts used 
in the model should be derived from same donor of PBMCs to avoid host immune cells 
reacting to MHC molecules expressed on fibroblasts. 
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I took part in further developing the EVG model and the results obtained so far are 
promising. The bioelectrosprayer can be utilised in cell culture experiments with improved 
readouts such as cell survival, matrix breakdown and Mtb growth studies. Developing a 
model where all these different parameters are involved together will allow dissecting the TB 
pathogenesis in greater detail and maximise the number of readouts per well. 
 
So in summary, although I have demonstrated that the ECM regulates cellular responses in 
TB, there is extensive further work that I would like to do to develop these findings, both 
from understanding the basic biology of how cell-matrix interactions control cellular 
behaviour to translational aspects whereby preventing excessive matrix breakdown may 
improve outcomes in TB. 
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13 APPENDICES 
 
13.1 Paper 
- The ECM regulates the host-pathogen interaction in tuberculosis. Basim Al shammari, 
Takayuki Shiomi, Liku Tezera, Magdalena Bielecka, Victoria Workman, Tara 
Sathyamoorthy,  Francesco Mauri, Suwan Jayasinghe, Brian D Robertson, Jeanine 
D’Armiento, Jon S Friedland and Paul T Elkington. Submitted, under review. 
 
13.2 Award 
- Travel grant award, awarded by British Society of Immunology (BSI) to attend and 
present at Keystone symposium in March 2013 at Whistler, British Columbia, 
Canada. 
 
13.3 Oral Presentations 
- Destruction of Lung ECM by MMP-1 is Critical in TB Pathogenesis. An oral 
presentation at Acid Fast Club (AFC) in January 2013 held in London, United 
Kingdom. 
- Infection of MMP-1 transgenic mice with virulent Mtb causes human-type lung 
pathology. A short talk at Keystone symposium ‘Tuberculosis: Understanding the 
Enemy’ in March 2013 held in Whistler, British Columbia, Canada. 
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13.4 Posters 
- Infection of MMP-1 transgenic mice with virulent Mtb causes human-type lung 
pathology. A poster presentation at Keystone symposium ‘Tuberculosis: 
Understanding the Enemy’ in March 2013 held in Whistler, British Columbia, 
Canada. 
- Cell-matrix interactions regulate the immune response to Mtb. A poster presentation 
at British Society of Immunology Congress (BSI Congress) in December 2013 held in 
Liverpool, United Kingdom. 
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14 ABBREVIATIONS 
 
BAL               Bronchalveolar lavage 
BCG  Bacille Calmette-Guèrin (vaccine) 
CFU                Colony Forming Unit 
CL3                 Containment level 3 
CNS                Central Nervous System 
 CoMtb  Conditioned media from monocytes stimulated with Mtb 
            EVG                Engineered in vitro granuloma 
 ECM  ECM 
           HIV                 Human Immunodeficiency Virus 
           IL                    Interleukin 
           IFN-γ              Interferon Gamma 
           IVG                In vitro granuloma 
           LAM              Lipoarabinomannan 
 Mtb  Mycobacterium tuberculosis 
 MDR  Multi-drug resistant 
 MGC  Multinucleated giant cell 
 MMP  Matrix metalloproteinase 
 MOI  Multiplicity of infection 
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           PIIINP             Procollagen III N-terminal Propeptide 
 PBMC  Peripheral blood mononucleated cell 
 PBS  Phosphate-buffered saline 
           PCR                Polymerase Chain Reaction 
 RT  Room temperature 
 SDS  Sodium dodecylsulphate 
 Tb  Tuberculosis 
           TIMP  Tissue Inhibitor of Metalloproteinase 
 TLR  Toll-Like Receptor 
           TNF-α             Tumour Necrosis Factor alpha 
 UV  Ultra-violet 
           WHO               World Health Organisation 
           WT                  Wild Type 
 XDR  Extensively drug resistant 
 
